cyclosporine has been researched along with Inflammation in 203 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 44 (21.67) | 18.2507 |
| 2000's | 58 (28.57) | 29.6817 |
| 2010's | 70 (34.48) | 24.3611 |
| 2020's | 31 (15.27) | 2.80 |
| Authors | Studies |
|---|---|
| An, H; Chang, DJ; Jung, JW; Kim, SO; Kim, WJ; Kim, YM; Lee, GB; Suh, YG; Yoon, EY | 1 |
| Edwards, BS; Graves, SW; Saunders, MJ; Sklar, LA; Zhu, J | 1 |
| Kim, YC; Ko, H; Lee, SM; Lee, WG | 1 |
| Brodowski, L; Meyer, N; Schröder-Heurich, B; von Kaisenberg, C; von Versen-Höynck, F | 1 |
| Annavajjhala, S; D'Souza, S; Mohapatra, A; Mullick, R; Shetty, R; Thakur, P | 1 |
| Elshazly, SM; Mahmoud, NM; Rezq, S | 1 |
| Choi, SH; Day, AJ; Dodd, RJ; Kim, HJ; Kim, YJ; Kouvatsos, N; Milner, CM; Oh, JY; Ryu, JS | 1 |
| Cheng, Y; Huan, M; Ji, Q; Liu, D; Liu, M; Mei, Q; Zhang, B; Zhou, S | 1 |
| Baudouin, C; Labetoulle, M; Leonardi, A; Pisella, PJ | 1 |
| Abu El-Asrar, AM; Albloushi, AF; Alkheraiji, NF; Almater, AI; Alromaih, AZ | 1 |
| Bohley, M; Braunger, BM; Dillinger, AE; Goepferich, A; Ohlmann, A; Schweda, F; Tamm, ER | 1 |
| Edwards Mayhew, RG; Leslie, L; Li, T; McCann, P; Palestine, AG; Strong Caldwell, A | 1 |
| Ahmad, S; Baudouin, C; Benitez Del Castillo, JM; Messmer, EM; Mrukwa-Kominek, E; Rolando, M; Vitovska, O | 1 |
| Bi, Z; Chen, C; Li, Y; Liang, Y; Liu, S; Shen, J; Yin, X; Zhao, X | 1 |
| Artesani, MC; Buzzonetti, L; Esposito, M; Fiocchi, AG; Valentini, D; Villani, A | 1 |
| Bohley, M; Braunger, BM; Dillinger, AE; Goepferich, A; Tamm, ER | 1 |
| Abe, K; Ait-Oufella, H; Alacamli, G; Alacamli, OG; Amir, O; Antar, S; Ashour, H; Azimonti, G; Baba, Y; Balogun, MM; Bampidis, V; Bastos, ML; Ben Hamouda, N; Bickel Haase, T; Bjornsson, R; Bostan, M; Braik, R; Brantom, P; Briggs, S; Bujor, I; Canbek, TD; Cherecheanu, AP; Chesson, A; Choudhary, RJ; Christensen, H; Chung, HR; Clavier, T; Dahman, NBH; Dani, S; Demailly, Z; Devine, LD; Ding, G; Duan, X; Durjava, M; Dusemund, B; Edebali, S; Elbaz Greener, G; Elnoby, AS; Fang, Q; Fares, AM; Fashola, MB; Fawzy, MS; Fouad, FM; Fu, SZ; Fujita, S; Furusawa, S; Gallagher, AM; Gao, J; Goyal, N; Guo, J; Hamuda, N; Han, Y; Hariri, G; Heist, EK; Hill, AJ; Homoud, M; Hu, Q; Hu, Z; Huang, L; Ide, T; Ikeda, M; Ishimaru, K; Jiang, C; Kaderli, ST; Kanamura, T; Karalezli, A; Kaur, P; Kazatsker, M; Kobo, O; Kouba, M; Kumar, R; Lavillegrand, JR; Leshem, E; Li, A; Li, S; Liu, R; López Puente, S; López-Alonso, M; Ma, M; Madias, C; Manini, P; Marcon, F; Margolis, G; Matsushima, S; Mayo, B; Miller, JE; Miyake, R; Miyamoto, HD; Naumann-Gola, S; Ortner, E; Pandit, R; Pang, Y; Pechová, A; Petkova, M; Pîrvulescu, R; Popa-Cherecheanu, A; Ramos, F; Roguin, A; Rozen, G; Ruskin, JN; Sanz, Y; Schweiggert-Weisz, U; Shafie, AAA; Sharma, H; Shi, X; Stoicescu, EA; Stopyra, W; Suh, JD; Sul, S; Tamion, F; Tiu, C; Tohyama, T; Tsutsui, H; Tsutsui, Y; Vandestienne, M; Villa, RE; Wang, P; Watanabe, M; Westendorf, J; Woutersen, R; Xia, J; Xing, W; Xu, X; Yang, L; Yang, N; Yu, J; Yu, M; Yu, X; Zhang, L; Zhao, Y; Zhao, Z; Zhou, X; Zorn, H | 1 |
| Li, P; Liu, C; Lu, W; Ma-Lauer, Y; Su, Z; von Brunn, A; Wu, A; Yang, F; Zhang, H; Zhu, D | 1 |
| Adhikari, N; Bang, SP; Jun, JH; Kim, H; Kim, JY; Lee, DC; Lee, HG; Neupane, S; Son, MJ; Yeon, CY | 1 |
| Du, Z; Li, N; Lu, C; Wu, D; Yuan, X; Zhang, M; Zhu, W | 1 |
| Ding, Z; Hu, Y; Jing, J; Jing, R; Liu, Y; Wang, S; Ye, L; Zhang, C | 1 |
| Mosca, M; Panzuti, P; Pin, D | 1 |
| Spradley, FT | 1 |
| Bao, J; Di, X; Han, X; Hu, B; Huang, Q; Liu, H; Yang, J | 1 |
| Liu, B; Tan, P | 1 |
| Lin, MC; Neri, P; Perez, VL; Periman, LM; Saban, DR | 1 |
| Janikowska, G; Janikowski, M; Janikowski, T; Kurzeja, E; Pyka-Pająk, A; Strzałka-Mrozik, B | 1 |
| Beckman, K; Katz, J; Majmudar, P; Rostov, A | 1 |
| Dihazi, GH; Dihazi, H; Eltoweissy, M; Jahn, O; Müller, GA; Tampe, B; Wülfrath, HS; Zeisberg, M | 1 |
| Das, P; Kumar, VL; Vangaveti, S | 1 |
| Alsharabati, M; King, P; Lu, L; Morgan, MB; Oh, SJ | 1 |
| Hu, JY; Liu, ZG; Yang, YR | 1 |
| Baillie, JK; Clohisey, S; Head Fourman, M; Law, A; Millar, JE; Parkinson, N; Rodgers, N; Russell, CD; Swets, MC; Wang, B; Zechner, M | 1 |
| Gui, Q; Jiang, Z; Zhang, L | 1 |
| Min, SN; Yu, GY; Zhu, YY | 1 |
| Amano, W; Hayashi, M; Kakimoto, K; Katsuda, Y; Kimoto, Y; Konishi, N; Shinozaki, Y; Taniai-Riya, E; Tanimoto, A; Toyoda, K; Yamamoto, Y | 1 |
| Bellon, H; Heigl, T; Hoet, P; Lammertyn, E; Vanaudenaerde, BM; Vandermeulen, E; Vanhove, T; Verleden, GM; Verleden, SE; Verlinden, L; Verstuyf, M; Vos, R; Vriens, H | 1 |
| Honda, H; Ito, Y; Kawamoto, T; Morita, O | 1 |
| Awan, Z; El-Bassossy, HM; El-Mas, MM | 1 |
| Eid, BG; El-Bassossy, HM | 1 |
| Berti, E; Damiani, G; Fiore, M; Leone, S; Maraolo, AE | 1 |
| Elbayoumi, T; Elgebaly, SA; Kreutzer, DL | 1 |
| Bartold, PM; Hughes, FJ | 1 |
| Ji, YW; Kang, HG; Kim, HC; Lee, HK; Moon, I; Noh, H; Song, JS; Yeo, A | 1 |
| Bi, S; Jia, B; Meng, W; Xiao, Z; Zhao, X | 1 |
| Fujino, M; Isaka, Y; Ito, H; Li, XK; Liu, C; Nakajima, M; Takahashi, K; Tanaka, T; Zhu, P; Zhuang, J | 1 |
| Amiji, M; Ferris, C; Kulkarni, P; Pawar, G; Yadav, S | 1 |
| Barabino, S; Baudouin, C; Daull, P; Docquier, M; Feraille, L; Garrigue, JS; Kessal, K; Parsadaniantz, SM | 1 |
| Jovanovic, R; Mitic, K; Nikolov, V; Pandilova, M; Popovska, M; Spasovski, G | 1 |
| Jiang, M; Li, F; Li, K; Luo, L; Meng, Q; Sun, C; Wang, C | 1 |
| Hodge, G; Hodge, S; Holmes, M; Jersmann, H; Reynolds, PN | 1 |
| Calder, V; Calonge, M; Gao, J; Lee, W; Sana, R; Stern, ME; Wheeler, LA | 1 |
| Cassel, SL; Eisenbarth, SC; Elliott, EI; Han, R; He, Q; Iyer, SS; Janczy, JR; Knepper-Adrian, V; Nauseef, WM; Olivier, AK; Qiao, L; Sadler, JJ; Sutterwala, FS; Zhong, Z | 1 |
| Ali, IS; Cantin, B; Carrier, M; Cecere, R; Groulx, A; Haddad, H; He, Y; Isaac, D; Kobashigawa, JA; Pflugfelder, PW; Ross, H; Touyz, RM; Wang, SH; White, M; Whittom, L | 1 |
| Fan, Y; Liu, A; Liu, F; Nicholson, ML; Shi, L; Wu, Y; Yang, B; Yang, C; Zhang, J; Zhang, Y; Zhu, T | 1 |
| Ge, S; Jordan, SC; Karasyov, A; Mirocha, J; Shin, BH; Toyoda, M; Vo, A | 1 |
| Afonso, M; Artese, L; De Oliveira Bello, V; Iaculli, F; Onuma, T; Perrotti, V; Piccirilli, M; Rapani, M; Shibli, JA; Sposto, MR | 1 |
| Cardinale, I; Czarnowicki, T; de Guzman Strong, C; Dhingra, N; Finney, R; Gilleaudeau, P; Gonzalez, J; Guttman-Yassky, E; Khattri, S; Krueger, JG; Rozenblit, M; Shemer, A; Suárez-Fariñas, M; Sullivan-Whalen, M; Xu, H; Zheng, X | 1 |
| Dutescu, RM; Merkel, OM; Panfil, C; Schrage, N | 1 |
| Fernandes, J; Nunes, S; Reis, F; Rocha-Pereira, P; Rodrigues-Santos, P; Santos-Silva, A; Sereno, J; Teixeira, F; Vala, H | 1 |
| Meseguer, A; Moreso, F; Sarró, E; Serón, D; Torres, IB | 1 |
| Chen, Z; Hong, T; Liu, C; Shao, M; Wang, C | 1 |
| Allain-Rooney, T; Dipchand, AI; He, Y; Manlhiot, C; Pollock-BarZiv, S; Touyz, RM; West, L; White, M | 1 |
| Atreya, I; Atreya, R; Daniel, C; Fischer, A; Hirschmann, S; Neumann, H; Neurath, M; Steiner, S; Waldner, M; Weigmann, B | 1 |
| Kirby, B; Ryan, C | 1 |
| Foulkes, AC; Warren, RB | 1 |
| Bukrinsky, M | 1 |
| Chhatrala, R; Driscoll, C; Luketic, V; Matherly, S; Puri, P; Sanyal, A; Sargeant, C; Sharma, A; Siddiqui, MB; Siddiqui, MS; Sterling, R; Stravitz, RT | 1 |
| Chen, P; Conway-Campbell, BL; Copland, DA; Dhanda, AD; Dick, AD; Gery, I; Hirani, S; Jawad, S; Lait, PJ; Lee, RW; Li, Z; Liu, B; Nussenblatt, RB; Schewitz-Bowers, LP; Sen, N; Tucker, W; Vistica, BP; Wakabayashi, Y; Wei, L; Williams, EL; Wu, W; Zhu, J | 1 |
| Albano, L; Anglicheau, D; Di Giambattista, F; Dubois, YC; Durrbach, A; Hazzan, M; Hertig, A; Hurault deLigny, B; Lang, P; Merville, P; Moulin, B; Quéré, S; Rondeau, E; Rostaing, L; Touchard, G; Vuiblet, V | 1 |
| Briggs, Z; Gardner, DH; Hou, TZ; Jeffery, LE; Raza, K; Sansom, DM; Soskic, B | 1 |
| Albert, D; Bergen, A; Burelle, Y; Malo, D; Marton, J; Park, R; Qureshi, S; Vidal, SM; Wiltshire, SA | 1 |
| Bao, J; Brennecke, SP; Hu, B; Huang, Q; Liu, H; Yang, J | 1 |
| Chan, HK; Onoue, S; Prud'homme, RK; Sato, H; Seto, Y; Suzuki, H; Wong, J; Yakushiji, K | 1 |
| Egido, J; González-Guerrero, C; Ocaña-Salceda, C; Ortiz, A; Ramos, AM; Rodrigues-Diez, R; Rodrigues-Diez, RR; Ruiz-Ortega, M | 1 |
| Cannata-Ortiz, P; Egido, J; González-Guerrero, C; Guerri, C; Ortiz, A; Ramos, AM | 1 |
| Amani, A; Dehpour, AR; Gilani, K; Mehr, SE; Nasoohi, S; Partoazar, A; Rahimi, N; Rezayat, SM | 1 |
| Gum, SI; Jung, JC; Kim, IG; Kim, YH; Lee, JS; Lee, KW; Park, YJ | 1 |
| Hossain, P | 1 |
| Banjar, ZM; El-Bassossy, HM; El-Mas, MM | 1 |
| Fujita, T; Kajiya, M; Kittaka, M; Kurihara, H; Matsuda, S; Okanobu, A; Shiba, H | 1 |
| Ohtsuka, T | 1 |
| Caryk, M; Janeczko, K; Setkowicz, Z; Szafraniec, M; Zmudzińska, A | 1 |
| Andoh, TF; Bennett, WM; Shihab, FS | 1 |
| Austen, B; Hewamana, S; Johnson, S; Murray, J; Wilson, K | 1 |
| Guzey, M; Karaman, SK; Ordulu, F; Satici, A; Sezer, S | 1 |
| Fujinaga, S; Hara, S; Murakami, H; Ohtomo, Y; Shimizu, T; Someya, T; Umino, D | 1 |
| Bilban, M; Hofer, E; Mayer, H; Sattler, S; Schweighofer, B; Sturtzel, C; Testori, J; Wagner, O | 1 |
| Chang, TY; Chang, YC; Tsai, CH | 1 |
| Daniel, E; Foster, CS; Gangaputra, S; Jabs, DA; Kaçmaz, RO; Kempen, JH; Levy-Clarke, GA; Newcomb, C; Nussenblatt, RB; Rosenbaum, JT; Suhler, EB; Thorne, JE | 1 |
| Hillman, T; Murphy, P; Rajakulasingam, K | 1 |
| Almodin, J; Fakhraie, G; Ichhpujani, P; Lopes, JF; Moster, MR; Spaeth, GL | 1 |
| Bae, EH; Choi, C; Kim, IJ; Kim, SW; Lee, J; Ma, SK; Park, JW | 1 |
| Bondada, S; Brandon, JA; Bryson, JS; Cohen, DA; Jennings, CD; Kaplan, AM; Perez, J; Sindhava, VJ | 1 |
| Haron, MM; Houssen, ME; Ibrahim, TM; Metwally, SS | 1 |
| Ge, H; He, B; Yuan, W | 1 |
| Erdal, R; Haberal, M; Özdemir, AA; Özdemir, BH; Özdemir, FN | 1 |
| Bernacki, J; Bielecka, A; Gabryel, B; Herman, ZS; Łabuzek, K | 1 |
| Chang, LT; Chen, YL; Chua, S; Kao, YH; Leu, S; Lin, YC; Shao, PL; Sun, CK; Tsai, TH; Yen, CH; Yip, HK; Yuen, CM | 1 |
| Montezano, AC; Touyz, RM; White, M | 1 |
| Allaire, E; Becquemin, JP; Dai, J; Desgranges, P; Franck, G; Gervais, M; Michineau, S | 1 |
| Brown, L; Coombes, JS; Fassett, RG; Shing, CM | 1 |
| Hatoya, S; Inaba, T; Kitamura, M; Nakayama, M; Nishida, H; Sugiura, K; Tanaka, H | 1 |
| Akhi, SN; Brännström, M; Groth, K; Mölne, J; Wranning, CA | 1 |
| Huynh-Ba, G; Johanson, M; Villar, CC; Zhao, XR | 1 |
| Jeltsch, M; Jokinen, JJ; Krebs, R; Lemström, KB; Nykänen, AI; Ropponen, JO; Tikkanen, JM; Ylä-Herttuala, S | 1 |
| Auer, VJ; Eppler, E; Janas, E; Kirchner, S; Ninichuk, V; Otto, AM; Stangl, MJ; Weiss, TS | 1 |
| de Oliveira, VL; Fasse, E; Hupkens, P; Joosten, I; Keijsers, RR; Koenen, HJ; Labuda, T; Latta, M; Norsgaard, H; Seyger, MM; Svensson, L; van de Kerkhof, PC; van Erp, PE | 1 |
| Hong, JH; Kim, SH; Lee, YC | 1 |
| Belaidi, E; Charles, AL; Diemunsch, P; Geny, B; Gharib, A; Guillot, M; Lejay, A; Pottecher, J | 1 |
| Bellón, JM; Buján, J; Corrales, C; Jurado, F; Rodriguez, M | 1 |
| Ahn, HJ; Bang, BK; Cha, JH; Kim, J; Kim, WY; Kim, YS; Li, C; Park, CW; Park, JH; Yang, CW | 1 |
| Corrigan, CJ | 1 |
| Russell, JH; Tripp, CS; Yu, JJ | 1 |
| Cleutjens, KB; Daemen, MJ; Donners, MM; Heeneman, S | 1 |
| Wilson, SE | 1 |
| Donnenfeld, ED; Perry, HD | 1 |
| Dannenberg, O; Haverich, A; Heublein, B; Oppelt, P; Pethig, K; Wahlers, T | 1 |
| Fröde, TS; Medeiros, YS; Monguilhott Dalmarco, E | 1 |
| Cabot, PJ; Do, M; Hermanussen, S | 1 |
| C Doherty, C; Connolly, JK; Courtney, AE; Herron, B; Jefferson, JA; McCarron, MO | 1 |
| Bernardi, P; Nicolosi, L; Soriano, ME | 1 |
| Burke, JT; Cook, DJ; Flechner, SM; Hammond, JA; Head, SR; Kurian, SM; Lanigan, CM; Rollin, H; Salomon, DR; Solez, K; Whisenant, T | 1 |
| Arbiser, J; Babichev, YO; Chang, W; Chen, S; Cruz, M; Dagnino, L; Dumont, DJ; Haninec, A; Jones, J; Jones, N; Jothy, S; Kerbel, RS; Klement, G; Master, Z; Sturk, C; Tran, J; Van Slyke, P; Voskas, D; Ward, N | 1 |
| Adams, MB; Hilton, G; Johnson, CP; Nilakantan, V; Pieper, GM; Roza, AM; Zhou, X | 1 |
| Planas, E; Pol, O; Poveda, R; Puig, MM; Romero, A; Sánchez, S | 1 |
| Blalock, EM; Chen, KC; Kadish, I; Kraner, SD; Landfield, PW; Norris, CM; Porter, NM; Thibault, V | 1 |
| Högger, P; Timmermann, M | 1 |
| Cha, JH; Kang, DH; Kang, SW; Kim, J; Kim, YS; Li, C; Lim, SW; Song, JC; Sun, BK; Yang, CW | 1 |
| Blijlevens, NM; DePauw, BE; Donnelly, JP | 1 |
| Bockmeyer, CL; Claus, RA; Deigner, HP; Kaufmann, R; Kentouche, K; Lösche, W; Oberle, V; Sieber, MW | 1 |
| De Santis, M; Ferraccioli, GF; Tomietto, P | 1 |
| Khanna, AK | 1 |
| Mutsuga, N; Nakayama, T; Tosato, G; Yao, L | 1 |
| Edlich, F; Fischer, G | 1 |
| Ban, K; Goto, K; Ito, K; Moriyama, A; Okada, S; Sugiura, T; Togari, H | 1 |
| Mizukawa, A; Nishikawa, S; Okisaka, S; Takagi, S | 1 |
| Azevedo, E; Burton, J; Davies, R; Ferguson, R; Genest, J; Giannetti, N; Haddad, H; Isaac, D; LeBlanc, MH; Pflugfelder, P; Racine, N; Ross, H; White, M | 1 |
| Ikeda, K; Shimizu, Y; Sugahara, S; Yamamoto, S | 1 |
| Emery, H; Grenert, J; Hermiston, M; Lam, W; Modica, R; von Scheven, E; Wirt, M | 1 |
| Chang, YC; Huang, FM; Lin, HJ; Tsai, CH | 1 |
| Costa, JE; Cota, LO; Ferreira, SD; Lages, EJ; Oliveira Costa, F; Oliveira, AM | 1 |
| Ayala, JM; Azimzadeh, AM; DeMartino, JA; Iliff, S; Kawka, DW; Lu, M; Lyons, K; Miller, GG; Mills, SG; Mudgett, JS; Nguyen, BN; Peterson, LB; Pierson, RN; Schröder, C; Siciliano, SJ; Singer, II; Springer, MS; Wu, G; Zhang, T | 1 |
| Bayes, B; Bonet, J; Homs, M; Lauzurica, R; Llopis, MA; Malumbres, S; Pastor, MC; Romero, R | 1 |
| Allen, SD; Duncan, FJ; Ferketich, AK; Kusewitt, DF; Martin, J; Oberyszyn, TM; Thomas-Ahner, JM; Tober, KL; Vanbuskirk, AM; Wulff, BC | 1 |
| Foulks, GN | 1 |
| Nascimento, NG; Olivo, RA; Silveira, PF; Teixeira, CF | 1 |
| Kaminuma, O | 1 |
| Baeza, E; Boulard, C; Delers, F; Poitou, I | 1 |
| Bonham, CA; Thomson, AW | 1 |
| Khatibnia, U; Utech, CI; Winter, PF; Wulle, KG | 1 |
| Ali, NM; Allende, MC; Bacher, J; Berenguer, J; Garrett, K; Lee, JW; Lyman, C; Pizzo, PA; Walsh, TJ | 1 |
| Calne, RY; Friend, PJ; Jamieson, NV; Rasmussen, A; Soin, AS; Watson, CJ; Wight, DG | 1 |
| Choudhury, AR; Furuta, GT; Galli, SJ; Lavigne, JA; Wang, ZS; Wershil, BK | 1 |
| Gough, J; Jeffery, JR; Rush, DN | 1 |
| Carter, L; Schäfer, M; Stein, C | 1 |
| Doranz, B; Engelhardt, JF; Wilson, JM; Ye, X | 1 |
| Bryson, JS; Caywood, BE; Jennings, CD; Kaplan, AM | 1 |
| Campbell, A; Dalton, HR; Jewell, DP; Merrett, MN; Winter, TA | 1 |
| Chaplin, D; Dawson, J; Geiger, T; Kunz, S; Nguyen, H; Rordorf-Adam, C; Towbin, H; Vosbeck, K; Zingel, O | 1 |
| Górski, A; Mrowiec, T; Paczek, L; Stepień-Sopniewska, B | 1 |
| Członkowski, A; Herz, A; Stein, C | 1 |
| Belitsky, P; Gulanikar, A; Gupta, R; He, G | 1 |
| Anderle, SK; Dieter Geratz, J; Pryzwansky, KB; Schwab, JH; Tidwell, RR | 1 |
| Cornblath, DR; Crawford, TO; Goldstein, JM; Griffin, JW; Mahattanakul, W | 1 |
| Beals, TF; Buechner-Maxwell, VA; Curtis, JL; Kim, S; Milik, AM; Seitzman, GD; Sonstein, J | 1 |
| Aoki, Y; Kao, PN | 1 |
| Billingham, ME; Hoyt, EG; Pollard, J; Poston, RS; Robbins, RC | 1 |
| Ahonen, J; Krogerus, L; Lautenschlager, I; Saarinen, O; Soots, A | 1 |
| Harjula, AL; Ikonen, T; Morris, RE; Salminen, US; Taskinen, E; Uusitalo, M | 1 |
| Halttunen, J; Häyry, P; Kuusanmäki, P; Lauronen, J; Paavonen, T; Pakarinen, M; Yilmaz, S | 1 |
| Abramovici, A; Keisari, Y; Kessler, OJ; Servadio, C | 1 |
| Hardinge, FM; Holgate, ST; Howarth, PH; Madden, J; Redington, AE | 1 |
| Celikel, CA; Celikel, T; Ceyhan, BB; Sungur, M | 1 |
| Celikel, CA; Celikel, T; Ceyhan, B; Sungur, M | 1 |
| Aliperta, M; De Marino, V; Marone, G; Spadaro, G; Triggiani, M | 1 |
| Toshida, H | 1 |
| Baan, CC; Balk, AH; Holweg, CT; Knoop, CJ; Mochtar, B; van der Ham, F; van Gelder, T; Weimar, W; Zondervan, PE | 1 |
| Sullivan, R | 1 |
| BaMaung, NY; Clark, RF; Fey, TA; Gauvin, DM; Gunawardana, IW; Henry, CL; Kawai, M; Kopecka, H; Krause, R; Lane, BC; Liu, L; Luly, JR; Marsh, K; Miller, L; Mollison, KW; Or, YS; Pong, M; Rhoades, TA; Sheets, MP; Smith, ML; Trevillyan, JM; Tu, NP; Wagner, R; Wiedeman, PE; Xie, Q | 1 |
| Dekaban, GA; Mabon, PJ; Weaver, LC | 1 |
| Boichot, E; Clément, B; Corbel, M; Germain, N; Lagente, V; Théret, N | 1 |
| Carreño, MA; Cuchacovich, M; Gatica, H; Verdaguer, J; Verdaguer, JI; Villarroel, F | 1 |
| Braza, F; Filipovic, Z; Kerr, SW; Nodop, SG; Noonan, TC; Winquist, RJ; Wolyniec, WW | 1 |
| de Bruin, RW; Dowling, J; Jablonski, P; Jin, XJ; Kouwenhoven, EA; Maguire, JA; Stein-Oakley, AN; Thomson, NM | 1 |
| Akiyama, K; Egan, RW; Kaminuma, O; Mori, A; Nakata, A; Ogawa, K; Okudaira, H | 1 |
| Garlington, S; Khavari, PA; Kirschberg, T; Kreider, E; Lin, Q; McGrane, PL; Rothbard, JB; Wender, PA | 1 |
| Kubota, T; Lynch, SV; Matsunami, H; Morioka, D; Nakatani, Y; Sekido, H; Shimada, H; Strong, RW; Takeda, K; Togo, S | 1 |
| Bellón, JM; Buján, J; Gimeno, MJ; Jurado, F; Rodriguez, M | 1 |
| Bradford, B; Enomoto, N; Ikejema, K; Rose, ML; Rusyn, I; Schemmer, P; Seabra, V; Stacklewitz, RF; Thurman, RG; Wheeler, MD; Yin, M; Zhong, Z | 1 |
| Inagaki, N; Kawada, N; Masuda, T; Nagai, H; Takahashi, Y; Takizawa, T; Tanaka, H; Yamada, T | 1 |
| Ando, K; Hayashi, S; Kimura, Y; Miyazawa, K; Mukai, K; Ohyashiki, K; Serizawa, H; Shimamoto, T; Yguchi, M | 1 |
| Pakkala, I; Pakkala, S; Räisänen-Sokolowski, A; Taskinen, E | 1 |
| Brinkmann, V; Chen, S; Feng, L; Pinschewer, DD | 1 |
| Bornhövd, E; Burgdorf, WH; Wollenberg, A | 1 |
| Battram, CH; Belvisi, MG; Birrell, MA; Dabrowski, D; Foster, ML; Haddad, el-B; McCluskie, K; Pecoraro, M; Underwood, SL | 1 |
| Das, UN; Koratkar, R; Madhavi, N; Padma, M; Ramesh, G; Sagar, PS; Sravankumar, G; Suryaprabha, P; Vijaykumar, K | 1 |
| Binkley, KE; Leznoff, A; Rabinovitch, T; Rootman, DS; Shea, M | 1 |
| Forrester, JV; Lightman, SL; Towler, HM | 1 |
| Dietze, O; Habringer, C; Klima, G; Königsrainer, A; Krausler, R; Margreiter, R | 1 |
| Kerr, JF; McCombe, PA; Nguyen, KB; Pender, MP | 1 |
| Canales-Treviño, ML; Martínez-Palomo, A; Tsutsumi, V | 1 |
28 review(s) available for cyclosporine and Inflammation
| Article | Year |
|---|---|
Ciclosporin A Cationic Emulsion 0.1% for the Management of Dry Eye Disease: Facts That Matter for Eye-Care Providers.
Topics: Cations; Cyclosporine; Dry Eye Syndromes; Emulsions; Humans; Inflammation; Randomized Controlled Trials as Topic; Tears | 2023 |
Non-biologic, steroid-sparing therapies for non-infectious intermediate, posterior, and panuveitis in adults.
Topics: Adult; Antirheumatic Agents; Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Inflammation; Macular Edema; Methotrexate; Mycophenolic Acid; Panuveitis; Steroids; Tacrolimus | 2022 |
Management of inflammation in dry eye disease: Recommendations from a European panel of experts.
Topics: Cyclosporine; Dry Eye Syndromes; Humans; Inflammation; Ophthalmic Solutions; Risk Factors; Tears | 2023 |
Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasms; Child; Conjunctivitis, Allergic; Cornea; COVID-19; Cyclosporine; Cytokines; Death, Sudden, Cardiac; Defibrillators, Implantable; Diet; Disease Models, Animal; Docetaxel; Double-Blind Method; Dry Eye Syndromes; Educational Status; Emulsions; Female; Fluorescein Angiography; Fluoresceins; Focus Groups; Heart Failure; Hemothorax; Humans; Inflammation; Keratoconus; Male; Meibomian Glands; Mice; Middle Aged; Multiple Sclerosis; Myocardial Infarction; Myocardium; Nerve Fibers; Nigeria; Obesity; Overweight; Pandemics; Primary Prevention; Prospective Studies; Qualitative Research; Registries; Retinal Ganglion Cells; Retinal Vessels; Schools; Sirolimus; Tertiary Care Centers; Th1 Cells; Th2 Cells; Tomography, Optical Coherence; Troponin I; Tumor Necrosis Factor-alpha; United States; Ventricular Remodeling | 2022 |
The Immunological Basis of Dry Eye Disease and Current Topical Treatment Options.
Topics: Administration, Topical; Clinical Decision-Making; Cyclosporine; Dry Eye Syndromes; Goblet Cells; Homeostasis; Humans; Immunologic Factors; Immunosuppressive Agents; Inflammation; Integrins; Intercellular Adhesion Molecule-1; Lacrimal Apparatus; Lymphocyte Function-Associated Antigen-1; Phenylalanine; Steroids; Sulfones; T-Lymphocytes; Tears | 2020 |
Loteprednol Etabonate for the Treatment of Dry Eye Disease.
Topics: Animals; Anti-Allergic Agents; Cyclosporine; Dry Eye Syndromes; Humans; Inflammation; Loteprednol Etabonate; Lubricant Eye Drops; Quality of Life | 2020 |
Dynamic data-driven meta-analysis for prioritisation of host genes implicated in COVID-19.
Topics: Algorithms; CD3 Complex; CD4 Antigens; Chemokine CXCL10; Computational Biology; COVID-19; Cyclophilin A; Cyclosporine; Databases, Genetic; Genome-Wide Association Study; Genomics; Humans; Immune System; Immunogenetics; Inflammation; Interleukin-1alpha; Microtubule-Associated Proteins; Proteomics | 2020 |
Insights into the modulatory role of cyclosporine A and its research advances in acute inflammation.
Topics: Acute Disease; Animals; Cyclosporine; Humans; Immunomodulation; Immunosuppressive Agents; Inflammation; Organ Transplantation; Reperfusion Injury; Sepsis; T-Lymphocytes; Wounds and Injuries | 2021 |
Liver Illness and Psoriatic Patients.
Topics: Autoimmune Diseases; Chemical and Drug Induced Liver Injury; Cyclosporine; Humans; Inflammation; Liver; Liver Diseases; Methotrexate; Psoriasis | 2018 |
Periodontal complications of prescription and recreational drugs.
Topics: Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Calcium Channel Blockers; Cannabis; Contraceptives, Oral; Cyclosporine; Diphosphonates; Gingiva; Gingival Overgrowth; Hallucinogens; Hormone Replacement Therapy; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Illicit Drugs; Immunosuppressive Agents; Inflammation; Methadone; Periodontal Diseases; Periodontal Index; Periodontium; Phenytoin; Platelet Aggregation Inhibitors; Tropanes | 2018 |
The Interplay between inflammation and fibrosis in kidney transplantation.
Topics: Cyclosporine; Fibrosis; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Inflammation; Kidney Transplantation; Tacrolimus | 2014 |
Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities.
Topics: Acitretin; Adipokines; Alcoholism; Antibodies, Monoclonal, Humanized; Cardiovascular Diseases; Comorbidity; Cyclosporine; Dermatologic Agents; Diabetes Mellitus; Fumarates; Humans; Immunosuppressive Agents; Inflammation; Metabolic Syndrome; Methotrexate; Obesity; Psoriasis; Risk Factors; Smoking; Tumor Necrosis Factor-alpha; Ustekinumab | 2015 |
Pharmacogenomics and the resulting impact on psoriasis therapies.
Topics: Acitretin; Cyclosporine; Cytokines; HLA-C Antigens; Humans; Immunosuppressive Agents; Inflammation; Keratolytic Agents; Methotrexate; Pharmacogenetics; Phototherapy; Polymorphism, Genetic; Precision Medicine; Psoriasis; Research Design; Tumor Necrosis Factor-alpha | 2015 |
Extracellular cyclophilins in health and disease.
Topics: Animals; Basigin; Cyclophilins; Cyclosporine; Humans; Immunosuppressive Agents; Inflammation; Signal Transduction | 2015 |
Therapeutic targets for persistent airway inflammation in refractory asthma.
Topics: Anti-Asthmatic Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Asthma; Cyclosporine; Drug Delivery Systems; Drug Resistance; Etanercept; Gold Compounds; Humans; Immunoglobulin G; Inflammation; Leukotriene Antagonists; Methotrexate; Omalizumab; Phosphodiesterase Inhibitors; Receptors, Tumor Necrosis Factor; Respiration Disorders | 2010 |
The role of the T cell in the immunopathogenesis of asthma.
Topics: Adult; Allergens; Anti-Asthmatic Agents; Asthma; CD4-Positive T-Lymphocytes; Chemokines; Child; Cyclosporine; Double-Blind Method; Drug Resistance; Glucocorticoids; Humans; Hypersensitivity, Immediate; Immunosuppressive Agents; Inflammation; Interleukins; Lymphocyte Activation; Randomized Controlled Trials as Topic; RNA, Messenger; T-Lymphocyte Subsets | 2000 |
Inflammation and restenosis: implications for therapy.
Topics: Coronary Restenosis; Cyclosporine; Humans; Immunosuppressive Agents; Inflammation; Inflammation Mediators; Sirolimus; Tacrolimus | 2003 |
Medications for dry eye syndrome: a drug-therapy review.
Topics: Adrenal Cortex Hormones; Cyclosporine; Drugs, Generic; Humans; Inflammation; Keratoconjunctivitis Sicca; Ophthalmic Solutions; Tears; United States | 2003 |
Rationale for T cell inhibition by cyclosporin A in major autoimmune diseases.
Topics: Arthritis, Rheumatoid; Autoimmune Diseases; CD28 Antigens; Colitis, Ulcerative; Cyclosporine; Cytokines; Dermatomyositis; Humans; Immune Tolerance; Immunosuppressive Agents; Inflammation; Lupus Erythematosus, Systemic; T-Lymphocytes | 2005 |
Pharmacological targeting of catalyzed protein folding: the example of peptide bond cis/trans isomerases.
Topics: Animals; Cardiovascular Diseases; Catalysis; Cyclophilins; Cyclosporine; Drug Design; Enzyme Inhibitors; Humans; Immunosuppressive Agents; Inflammation; Neoplasms; NIMA-Interacting Peptidylprolyl Isomerase; Peptidylprolyl Isomerase; Protein Folding; Reperfusion Injury; Skin Diseases; Tacrolimus Binding Protein 1A | 2006 |
Pharmacological management of dry eye in the elderly patient.
Topics: Aged; Anti-Inflammatory Agents; Cyclosporine; Dry Eye Syndromes; Fatty Acids, Essential; Glucocorticoids; Humans; Inflammation; Lubrication; Ophthalmic Solutions; Serum | 2008 |
Selective inhibitors of nuclear factor of activated T cells: potential therapeutic drugs for the treatment of immunological and inflammatory diseases.
Topics: Animals; Calcineurin; Cyclosporine; Humans; Immune System Diseases; Immunosuppressive Agents; Inflammation; Lymphocyte Activation; NFATC Transcription Factors; Tacrolimus | 2008 |
Anti-inflammatory agents in allergic diseases.
Topics: Anti-Inflammatory Agents; Cyclosporine; Humans; Hypersensitivity; Inflammation | 1995 |
Immunopharmacology of human mast cells and basophils.
Topics: Adenylyl Cyclases; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Basophils; CD40 Ligand; Cyclosporine; Cytokines; Enzyme Activation; Enzyme Inhibitors; Glucocorticoids; Histamine Release; Humans; Inflammation; Mast Cells; Membrane Glycoproteins; Organ Specificity; Phosphodiesterase Inhibitors; Protein Kinase C; Protein-Tyrosine Kinases; Steroids; Tacrolimus | 1998 |
Discovery of ascomycin analogs with potent topical but weak systemic activity for treatment of inflammatory skin diseases.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Cyclosporine; Dermatitis; Drug Design; Humans; Immunosuppressive Agents; Inflammation; Interleukin-2; Skin Diseases; T-Lymphocytes; Tacrolimus | 1998 |
Glycine: a new anti-inflammatory immunonutrient.
Topics: Alcohols; Animals; Anti-Inflammatory Agents; Calcium Channels, L-Type; Chloride Channels; Cyclosporine; Free Radicals; Glycine; Hepatitis, Alcoholic; Humans; Hypoxia; Inflammation; Kupffer Cells; Leukocytes; Melanoma; Reperfusion Injury; Shock, Septic; Taurine | 1999 |
FTY720: altered lymphocyte traffic results in allograft protection.
Topics: Animals; Autoimmune Diseases; Cell Movement; Chemokines; Clinical Trials as Topic; Cyclosporine; Diabetes Mellitus, Type 1; Fingolimod Hydrochloride; Graft Rejection; Graft Survival; Humans; Immunologic Memory; Immunosuppressive Agents; Inflammation; Islets of Langerhans Transplantation; Lymphocyte Activation; Lymphocytes; Models, Animal; Propylene Glycols; Safety; Sphingosine; Transplantation, Homologous | 2001 |
Macrolactam immunomodulators for topical treatment of inflammatory skin diseases.
Topics: Administration, Topical; Clinical Trials as Topic; Cyclosporine; Dermatitis, Atopic; Humans; Immunosuppressive Agents; Inflammation; Sirolimus; Skin Diseases; Tacrolimus | 2001 |
15 trial(s) available for cyclosporine and Inflammation
| Article | Year |
|---|---|
Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasms; Child; Conjunctivitis, Allergic; Cornea; COVID-19; Cyclosporine; Cytokines; Death, Sudden, Cardiac; Defibrillators, Implantable; Diet; Disease Models, Animal; Docetaxel; Double-Blind Method; Dry Eye Syndromes; Educational Status; Emulsions; Female; Fluorescein Angiography; Fluoresceins; Focus Groups; Heart Failure; Hemothorax; Humans; Inflammation; Keratoconus; Male; Meibomian Glands; Mice; Middle Aged; Multiple Sclerosis; Myocardial Infarction; Myocardium; Nerve Fibers; Nigeria; Obesity; Overweight; Pandemics; Primary Prevention; Prospective Studies; Qualitative Research; Registries; Retinal Ganglion Cells; Retinal Vessels; Schools; Sirolimus; Tertiary Care Centers; Th1 Cells; Th2 Cells; Tomography, Optical Coherence; Troponin I; Tumor Necrosis Factor-alpha; United States; Ventricular Remodeling | 2022 |
Cardiac signaling molecules and plasma biomarkers after cardiac transplantation: impact of tacrolimus versus cyclosporine.
Topics: Adult; Aged; Apoptosis; Biomarkers; Cell Proliferation; Cyclosporine; Cytokines; E-Selectin; Female; Glutathione; Heart Transplantation; Humans; Immunosuppressive Agents; Inflammation; Intercellular Adhesion Molecule-1; Male; MAP Kinase Signaling System; Middle Aged; Mitogen-Activated Protein Kinase Kinases; Oxidative Stress; Prospective Studies; Signal Transduction; Tacrolimus; Thiobarbituric Acid Reactive Substances | 2013 |
Myocyte growth, repair, and oxidative stress following pediatric heart transplantation.
Topics: Adolescent; Biomarkers; Biopsy; Cell Proliferation; Child; Child, Preschool; Cyclosporine; Female; Heart Failure; Heart Transplantation; Humans; Infant; Inflammation; Male; Muscle Cells; Oxidative Stress; Oxygen; Postoperative Period; Prospective Studies; Signal Transduction; Tacrolimus; Treatment Outcome | 2014 |
Fibrosis progression according to epithelial-mesenchymal transition profile: a randomized trial of everolimus versus CsA.
Topics: Adolescent; Adult; Aged; Biopsy; Calcineurin Inhibitors; Cyclosporine; Disease Progression; Epithelial-Mesenchymal Transition; Everolimus; Female; Fibrosis; Graft Survival; Humans; Immunosuppression Therapy; Inflammation; Kidney; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Renal Insufficiency; Risk Factors; Treatment Outcome | 2015 |
The correlation between response to oral cyclosporin therapy and systemic inflammation, metabolic abnormality in patients with psoriasis.
Topics: Administration, Oral; Adult; Aged; Blood Glucose; Body Mass Index; C-Reactive Protein; Cholesterol, HDL; Cyclosporine; Dermatologic Agents; Dose-Response Relationship, Drug; Female; Humans; Inflammation; Male; Middle Aged; Psoriasis | 2008 |
Effects of postoperative cyclosporine ophthalmic emulsion 0.05% (Restasis) following glaucoma surgery.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Blister; Conjunctiva; Cyclosporine; Double-Blind Method; Female; Glaucoma; Humans; Immunosuppressive Agents; Inflammation; Intraocular Pressure; Male; Middle Aged; Ophthalmic Solutions; Postoperative Complications; Prospective Studies; Time Factors; Trabeculectomy | 2009 |
Mycophenolate mofetil for secondary prevention of cardiac allograft vasculopathy: influence on inflammation and progression of intimal hyperplasia.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; C-Reactive Protein; Cyclosporine; Female; Heart Transplantation; Humans; Hyperplasia; Immunosuppressive Agents; Inflammation; Male; Mycophenolic Acid; Pilot Projects; Prednisolone; Prospective Studies; Ultrasonography | 2004 |
De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years.
Topics: Adult; Aged; Biopsy; Calcineurin Inhibitors; Cyclosporine; Graft Survival; Humans; Immunosuppressive Agents; Inflammation; Kidney Function Tests; Kidney Transplantation; Middle Aged; Oligonucleotide Array Sequence Analysis; Prednisone; Sirolimus; Time Factors; Transplantation, Homologous; Treatment Outcome | 2004 |
Subclinical inflammation and prothrombotic state in heart transplant recipients: impact of cyclosporin microemulsion vs. tacrolimus.
Topics: Adult; Aged; Biomarkers; Blood Pressure; C-Reactive Protein; Cyclosporine; Dyslipidemias; Emulsions; Heart Transplantation; Hemostasis; Humans; Immunosuppressive Agents; Inflammation; Middle Aged; Postoperative Complications; Tacrolimus; Thrombosis | 2006 |
Subclinical inflammation in renal transplant recipients: impact of cyclosporine microemulsion versus tacrolimus.
Topics: Cyclosporine; Emulsions; Follow-Up Studies; Humans; Immunosuppressive Agents; Inflammation; Kidney Transplantation; Multivariate Analysis; Prospective Studies; Tacrolimus | 2007 |
MR T2 relaxation time for the assessment of retrobulbar inflammation in Graves' ophthalmopathy.
Topics: Adrenal Cortex Hormones; Adult; Aged; Cyclosporine; Drug Therapy, Combination; Female; Graves Disease; Humans; Immunosuppression Therapy; Inflammation; Intraocular Pressure; Magnetic Resonance Imaging; Male; Middle Aged; Oculomotor Muscles; Orbit | 1995 |
Sequential protocol biopsies in renal transplant patients: repeated inflammation is associated with impaired graft function at 1 year.
Topics: Adult; Biopsy, Needle; Cyclosporine; Diltiazem; Follow-Up Studies; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Inflammation; Kidney Transplantation; Predictive Value of Tests; Time Factors | 1995 |
Cyclosporin A retention enemas in refractory distal ulcerative colitis and 'pouchitis'.
Topics: Adult; Colitis, Ulcerative; Cyclosporine; Enema; Female; Humans; Inflammation; Male; Postoperative Complications; Proctocolectomy, Restorative; Sigmoidoscopy | 1993 |
[Treatment of non infectious ocular inflammatory disease with low doses of cyclosporin A].
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Chronic Disease; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Eye Diseases; Female; Humans; Immunosuppressive Agents; Inflammation; Male; Middle Aged; Prednisone; Prospective Studies; Radioimmunodetection | 1999 |
Low-dose cyclosporin therapy of ocular inflammation: preliminary report of a long-term follow-up study.
Topics: Blood Pressure; Creatinine; Cyclosporine; Eye Diseases; Follow-Up Studies; Humans; Inflammation; Visual Acuity | 1992 |
161 other study(ies) available for cyclosporine and Inflammation
| Article | Year |
|---|---|
Design, synthesis and identification of novel colchicine-derived immunosuppressant.
Topics: Animals; Autoimmune Diseases; Chemistry, Pharmaceutical; Colchicine; Cyclosporine; Drug Design; Gout Suppressants; Graft Rejection; Humans; Immunosuppressive Agents; Inflammation; Inhibitory Concentration 50; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Rats; Skin Transplantation; Structure-Activity Relationship | 2009 |
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature | 2010 |
Synthesis and biological evaluation of α,β-unsaturated lactones as potent immunosuppressive agents.
Topics: Cytotoxicity Tests, Immunologic; Drug Evaluation, Preclinical; Humans; Immunosuppressive Agents; Inflammation; Inhibitory Concentration 50; Interleukin-2; Jurkat Cells; Lactones; Molecular Structure; Structure-Activity Relationship; T-Lymphocytes | 2011 |
Cyclosporine A and Tacrolimus Induce Functional Impairment and Inflammatory Reactions in Endothelial Progenitor Cells.
Topics: Cardiovascular Diseases; Cell Movement; Cell Proliferation; Chemotaxis; Cyclosporine; Cytokines; Endothelial Cells; Endothelial Progenitor Cells; Humans; Immunosuppressive Agents; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-6; Neovascularization, Pathologic; NF-kappa B; NF-kappa B p50 Subunit; Sesquiterpenes; Signal Transduction; Stem Cells; Tacrolimus; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2021 |
Efficacy of topical cyclosporine 0.05% and osmoprotective lubricating eye drops in treating dry eye disease and inflammation.
Topics: Cyclosporine; Dry Eye Syndromes; Humans; Inflammation; Lubricant Eye Drops; Prospective Studies; Tears | 2021 |
Geraniol protects against cyclosporine A-induced renal injury in rats: Role of Wnt/β-catenin and PPARγ signaling pathways.
Topics: Acute Kidney Injury; Acyclic Monoterpenes; Animals; Apoptosis; beta Catenin; Cyclosporine; Inflammation; Kidney; Kidney Diseases; Male; NF-kappa B; PPAR gamma; Rats; Rats, Wistar; Wnt Signaling Pathway | 2022 |
The Link module of human TSG-6 (Link_TSG6) promotes wound healing, suppresses inflammation and improves glandular function in mouse models of Dry Eye Disease.
Topics: Animals; Cell Adhesion Molecules; Cyclosporine; Disease Models, Animal; Dry Eye Syndromes; Humans; Inflammation; Mice; Mice, Inbred NOD; Tears; Wound Healing | 2022 |
Cyclosporine A loaded brain targeting nanoparticle to treat cerebral ischemia/reperfusion injury in mice.
Topics: Animals; Brain; Brain Ischemia; Cyclosporine; Inflammation; Ischemia; Ischemic Stroke; Mice; Mitochondrial Permeability Transition Pore; Nanoparticles; Reactive Oxygen Species; Reperfusion Injury | 2022 |
Outcomes of initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease occurred during pregnancy.
Topics: Acute Disease; Adrenal Cortex Hormones; Cyclosporine; Female; Humans; Inflammation; Male; Pregnancy; Retrospective Studies; Uveitis; Uveomeningoencephalitic Syndrome | 2023 |
A single intravenous injection of cyclosporin A-loaded lipid nanocapsules prevents retinopathy of prematurity.
Topics: Animals; Cyclosporine; Humans; Infant, Newborn; Inflammation; Injections, Intravenous; Lipids; Mice; Nanocapsules; Retinopathy of Prematurity; Vascular Endothelial Growth Factor A | 2022 |
Cyclosporin A improves the hyperosmotic response in an experimental dry eye model by inhibiting the HMGB1/TLR4/NF-κB signaling pathway.
Topics: Animals; Cyclosporine; Dry Eye Syndromes; HMGB1 Protein; Humans; Inflammation; Mice; NF-kappa B; Signal Transduction; Toll-Like Receptor 4 | 2023 |
Vernal keratoconjunctivitis in Down syndrome: a case report.
Topics: Adolescent; Conjunctiva; Conjunctivitis, Allergic; Cornea; Cyclosporine; Down Syndrome; Female; Humans; Inflammation | 2023 |
Intravenous injection of cyclosporin A loaded lipid nanocapsules fights inflammation and immune system activation in a mouse model of diabetic retinopathy.
Topics: Animals; Cyclosporine; Cytokines; Diabetes Mellitus; Diabetic Retinopathy; Disease Models, Animal; Humans; Immune System; Inflammation; Injections, Intravenous; Lipids; Nanocapsules | 2023 |
Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2-Induced Inflammation.
Topics: COVID-19; Cyclophilin A; Cyclosporine; Humans; Inflammation; SARS-CoV-2 | 2023 |
Cyclosporine A eyedrops with self-nanoemulsifying drug delivery systems have improved physicochemical properties and efficacy against dry eye disease in a murine dry eye model.
Topics: Animals; Apoptosis; Cell Count; Conjunctiva; Cyclosporine; Cytokines; Disease Models, Animal; Drug Delivery Systems; Dry Eye Syndromes; Emulsions; Epithelium, Corneal; Fluorescein; Goblet Cells; Hydrogen-Ion Concentration; Inflammation; Ki-67 Antigen; Mice; Nanoparticles; Nephelometry and Turbidimetry; Ophthalmic Solutions; Particle Size; Tears; Treatment Outcome; Viscosity | 2019 |
Taxifolin attenuates IMQ-induced murine psoriasis-like dermatitis by regulating T helper cell responses via Notch1 and JAK2/STAT3 signal pathways.
Topics: Animals; Cell Line; Cell Proliferation; Cyclosporine; Cytokines; Dermatitis; Humans; Imiquimod; Inflammation; Janus Kinase 2; Keratinocytes; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Models, Animal; Psoriasis; Quercetin; Receptor, Notch1; Signal Transduction; Skin; STAT3 Transcription Factor; T-Lymphocytes; Transcription Factors | 2020 |
Dependence of sperm structural and functional integrity on testicular calcineurin isoform PPP3R2 expression.
Topics: Animals; Antibodies; ATP Binding Cassette Transporter 1; Biological Transport; Calcineurin; Calcium; Cell Membrane; Cholesterol; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclosporine; Cytokines; Diffusion; Hormones; Inflammation; Isoenzymes; Male; Membrane Fluidity; Mice, Inbred C57BL; Mice, Knockout; Sperm Motility; Spermatozoa; Testis | 2020 |
Granulomatous mural folliculitis in a dog treated with ciclosporin and methotrexate.
Topics: Alopecia; Animals; Cyclosporine; Disease Management; Dog Diseases; Dogs; Female; Folliculitis; Histological Techniques; Inflammation; Methotrexate; Skin; Skin Diseases | 2020 |
Targeting inflammation to reduce seizure severity in an experimental model of eclampsia.
Topics: Animals; Cyclosporine; Eclampsia; Female; Inflammation; Models, Theoretical; Pregnancy; Rats; Seizures | 2020 |
Cyclosporin A ameliorates eclampsia seizure through reducing systemic inflammation in an eclampsia-like rat model.
Topics: Animals; Blood Pressure; Cyclosporine; Cytokines; Disease Models, Animal; Eclampsia; Female; Immunosuppressive Agents; Inflammation; Pregnancy; Rats; Seizures | 2020 |
PPAR γ/TLR4/TGF-β1 axis mediates the protection effect of erythropoietin on cyclosporin A-induced chronic nephropathy in rat.
Topics: Animals; Cyclosporine; Cytokines; Erythropoietin; Fibrosis; Inflammation; Kidney; Male; PPAR gamma; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Toll-Like Receptor 4; Transforming Growth Factor beta1 | 2020 |
The Effect of Cyclosporine A on Dermal Fibroblast Cell - Transcriptomic Analysis of Inflammatory Response Pathway.
Topics: Cell Culture Techniques; Cell Line; Cell Survival; Cyclosporine; Dose-Response Relationship, Drug; Fibroblasts; Gene Expression Profiling; Humans; Immunosuppressive Agents; Inflammation; Oligonucleotide Array Sequence Analysis; RNA, Messenger; Skin; Transcriptome; Up-Regulation | 2020 |
The Secretome Analysis of Activated Human Renal Fibroblasts Revealed Beneficial Effect of the Modulation of the Secreted Peptidyl-Prolyl Cis-Trans Isomerase A in Kidney Fibrosis.
Topics: Cell Line, Transformed; Cell Survival; Cyclosporine; Disease Progression; Down-Regulation; Extracellular Matrix; Fibroblasts; Fibronectins; Fibrosis; Humans; Inflammation; Kidney; Peptidylprolyl Isomerase; Phenotype; Proteome; RNA, Small Interfering; Tacrolimus | 2020 |
Metformin and silymarin afford protection in cyclosporine A induced hepatorenal toxicity in rat by modulating redox status and inflammation.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cyclosporine; Inflammation; Kidney Diseases; Male; Metformin; Oxidation-Reduction; Rats; Rats, Wistar; Silymarin | 2021 |
Chronic inflammatory axonal polyneuropathy.
Topics: Adolescent; Adult; Aged; Autoimmune Diseases of the Nervous System; Axons; Azathioprine; Biopsy; Child; Child, Preschool; Chronic Disease; Cyclophosphamide; Cyclosporine; Electromyography; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Inflammation; Male; Middle Aged; Mycophenolic Acid; Neural Conduction; Polyneuropathies; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Sural Nerve; Young Adult | 2020 |
[The value and application prospect of cyclosporine A in the treatment of dry eye].
Topics: Cyclosporine; Dry Eye Syndromes; Humans; Inflammation; Ophthalmic Solutions | 2020 |
[Effect of topical injection of cyclosporine A on saliva secretion and inflammation in the submandibular gland of non-obese diabetic mice].
Topics: Animals; Cyclosporine; Diabetes Mellitus, Experimental; Disease Models, Animal; Female; Inflammation; Mice; Mice, Inbred NOD; Saliva; Sjogren's Syndrome; Submandibular Gland | 2021 |
A novel JAK inhibitor JTE-052 reduces skin inflammation and ameliorates chronic dermatitis in rodent models: Comparison with conventional therapeutic agents.
Topics: Animals; Cyclosporine; Cytokines; Dermatitis, Atopic; Female; Haptens; Humans; Immunoglobulin E; Inflammation; Interleukin-23; Interleukin-23 Subunit p19; Janus Kinase Inhibitors; Male; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Pyrroles; Rats; Rats, Inbred BN; Skin; Thymic Stromal Lymphopoietin | 2018 |
The Effect of Immunosuppression on Airway Integrity.
Topics: Azathioprine; Bronchiolitis Obliterans; Cyclosporine; Dexamethasone; Endothelial Cells; Epithelial Cells; Epithelial-Mesenchymal Transition; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Inflammation; Interleukin-8; Lung; Lung Transplantation; Microcirculation; Mycophenolic Acid; Permeability; Tacrolimus; Tight Junctions | 2017 |
Mechanism-based risk assessment strategy for drug-induced cholestasis using the transcriptional benchmark dose derived by toxicogenomics.
Topics: Administration, Oral; Animals; Chlorpromazine; Cholestasis; Cholesterol; Cyclosporine; Diclofenac; Dose-Response Relationship, Drug; Flutamide; Gene Expression; Humans; Imipramine; Inflammation; Ketoconazole; Liver; Methyltestosterone; Oxidative Stress; Rats; Risk Assessment; Sulindac; Tamoxifen; Toxicogenetics | 2017 |
Perinatal ciclosporin A exposure elicits sex-related cardiac dysfunction and inflammation in the rat progeny.
Topics: Adiponectin; Animals; Animals, Newborn; Catalase; Cyclosporine; Dinoprost; Electrocardiography; Female; Heart Failure; Heart Ventricles; Hemodynamics; Inflammation; Male; Oxidative Stress; Perinatal Care; Rats; Rats, Wistar; Sex Factors; Tumor Necrosis Factor-alpha; Ventricular Function, Left | 2017 |
Cyclosporine A exhibits gender-specific nephrotoxicity in rats: Effect on renal tissue inflammation.
Topics: Animals; Creatine; Cyclosporine; Female; Immunosuppressive Agents; Inflammation; Kidney; Kidney Diseases; Male; Rats; Rats, Wistar; Sex Characteristics; Sex Factors | 2018 |
CYCLOSPORIN H: A NOVEL ANTI-INFLAMMATORY THERAPY FOR INFLUENZA FLU PATIENTS.
Topics: Animals; Anti-Inflammatory Agents; Chemotaxis, Leukocyte; Cyclosporine; Dogs; Female; Humans; Inflammation; Influenza A Virus, H1N1 Subtype; Influenza, Human; Leukocytes; Madin Darby Canine Kidney Cells; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Necrosis; Staphylococcal Infections | 2017 |
Comparison of Ocular Surface Mucin Expression After Topical Ophthalmic Drug Administration in Dry Eye-Induced Mouse Model.
Topics: Administration, Topical; Alanine; Animals; Anti-Inflammatory Agents; Cyclosporine; Disease Models, Animal; Dry Eye Syndromes; Epithelium, Corneal; Female; Inflammation; Mice; Mice, Inbred C57BL; Mucins; Ophthalmic Solutions; Polyphosphates; Quinolones; Uracil Nucleotides | 2018 |
Attenuation of Lipopolysaccharide-Induced Acute Lung Injury by Cyclosporine-A via Suppression of Mitochondrial DNA.
Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; Cyclosporine; Cytokines; DNA, Mitochondrial; Inflammation; Interleukin-6; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred C57BL; Sepsis | 2018 |
5-aminolaevulinic acid (ALA), enhances heme oxygenase (HO)-1 expression and attenuates tubulointerstitial fibrosis and renal apoptosis in chronic cyclosporine nephropathy.
Topics: Aminolevulinic Acid; Animals; Apoptosis; Atrophy; Cyclosporine; Cytokines; Drug Therapy, Combination; Fibrosis; Heme Oxygenase-1; Inflammation; Iron; Levulinic Acids; Mice; Nephritis, Interstitial; Oxidative Stress; RNA, Messenger | 2019 |
CNS Delivery and Anti-Inflammatory Effects of Intranasally Administered Cyclosporine-A in Cationic Nanoformulations.
Topics: Administration, Intranasal; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Central Nervous System; Cyclosporine; Cytokines; Drug Compounding; Drug Delivery Systems; Emulsions; Fatty Acids, Omega-3; Inflammation; Linseed Oil; Lipopolysaccharides; Magnetic Resonance Imaging; Male; Nanostructures; Rats; Rats, Sprague-Dawley | 2019 |
Modulation of Inflammation-Related Genes in the Cornea of a Mouse Model of Dry Eye upon Treatment with Cyclosporine Eye Drops.
Topics: Administration, Ophthalmic; Animals; Cornea; Cyclosporine; Cytokines; Disease Models, Animal; Dry Eye Syndromes; Female; Fluorescein; Fluorescent Dyes; Gene Expression Regulation; Genetic Markers; Immunosuppressive Agents; Inflammation; Mice; Mice, Inbred C57BL; Ophthalmic Solutions; Receptors, Cytokine; RNA, Messenger; Tears | 2019 |
The role of inflammation and apoptosis in cyclosporine A-induced gingival overgrowth.
Topics: Apoptosis; Cyclosporine; Gingival Overgrowth; Humans; Immunosuppressive Agents; Inflammation; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53 | 2013 |
Cyclosporin A attenuates weight gain and improves glucose tolerance in diet-induced obese mice.
Topics: Adipocytes; Adipose Tissue, White; Animals; Blood Glucose; Cell Differentiation; Cyclosporine; Diabetes Mellitus, Type 2; Eating; fas Receptor; Glucose; Glucose-6-Phosphatase; Immunosuppressive Agents; Inflammation; Insulin Resistance; Interleukin-12; Interleukin-1beta; Interleukin-2; JNK Mitogen-Activated Protein Kinases; Lipid Metabolism; Mice; Obesity; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR gamma; Protein Serine-Threonine Kinases; Signal Transduction; Stearoyl-CoA Desaturase; Transcription Factors; Tumor Necrosis Factor-alpha; Weight Gain | 2013 |
The drug efflux pump Pgp1 in pro-inflammatory lymphocytes is a target for novel treatment strategies in COPD.
Topics: Aged; Anti-Inflammatory Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Cytokines; Female; Granzymes; Humans; Inflammation; Leukocyte Count; Lymphocytes; Male; Methylprednisolone; Middle Aged; Pulmonary Disease, Chronic Obstructive; T-Lymphocytes, Cytotoxic | 2013 |
Mitochondrial permeability transition pore in inflammatory apoptosis of human conjunctival epithelial cells and T cells: effect of cyclosporin A.
Topics: Apoptosis; Caspases; Cell Death; Cells, Cultured; Conjunctiva; Conjunctival Diseases; Cyclosporine; Epithelial Cells; Fas Ligand Protein; fas Receptor; Humans; Immunosuppressive Agents; Inflammation; Interferon-gamma; Jurkat Cells; Membrane Potential, Mitochondrial; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2013 |
Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation.
Topics: Acetamides; Animals; Cardiolipins; Carrier Proteins; Cell Line; Cyclosporine; Enzyme Activation; Humans; Inflammasomes; Inflammation; Interleukin-1beta; Interleukin-6; Linezolid; Macrophages; Mice; Mitochondria; NLR Family, Pyrin Domain-Containing 3 Protein; Oxazolidinones; Potassium; Reactive Oxygen Species; Signal Transduction; Tumor Necrosis Factor-alpha | 2013 |
Protective effects of HBSP on ischemia reperfusion and cyclosporine a induced renal injury.
Topics: Acute Kidney Injury; Animals; Apoptosis; Caspase 3; Cyclosporine; Enzyme Activation; Erythropoietin; Fibrosis; Gene Expression; Inflammation; Kidney; Kidney Function Tests; Male; Peptide Fragments; Protective Agents; Rats; Reperfusion Injury; RNA, Messenger | 2013 |
Regulation of anti-HLA antibody-dependent natural killer cell activation by immunosuppressive agents.
Topics: Antibodies; Antibody-Dependent Cell Cytotoxicity; Calcineurin Inhibitors; CD56 Antigen; Cyclosporine; Dose-Response Relationship, Drug; Flow Cytometry; Gene Expression Regulation; HLA Antigens; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Inflammation; Interferon-gamma; Killer Cells, Natural; Leukocytes, Mononuclear; Lysosomal-Associated Membrane Protein 1; Mycophenolic Acid; Risk; Sirolimus; Tacrolimus | 2014 |
Immunoexpression of angiogenesis and proliferation markers in patients treated with cyclosporin A.
Topics: Adult; Aged; Biomarkers; Biopsy; Cyclosporine; Female; Gingiva; Gingival Hypertrophy; Humans; Immunoenzyme Techniques; Immunosuppressive Agents; Inflammation; Ki-67 Antigen; Kidney Transplantation; Male; Middle Aged; Neovascularization, Physiologic; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Periodontitis; Postoperative Complications; Vascular Endothelial Growth Factor A; Young Adult | 2014 |
Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology.
Topics: Adolescent; Adult; Aged; Biomarkers; Cluster Analysis; Cyclosporine; Dendritic Cells; Dermatitis, Atopic; Epidermis; Female; Gene Expression Profiling; Gene Expression Regulation; Humans; Hyperplasia; Immunosuppressive Agents; Inflammation; Male; Middle Aged; Phenotype; Signal Transduction; T-Lymphocyte Subsets; Treatment Outcome; Young Adult | 2014 |
Semifluorinated alkanes as a liquid drug carrier system for topical ocular drug delivery.
Topics: Administration, Topical; Alkanes; Animals; Castor Oil; Cornea; Cyclosporine; Drug Carriers; Eye; Eye Diseases; Fluorescein; Fluorine; Glucose; Inflammation; Kinetics; Lactic Acid; Lipids; Rabbits; Solvents | 2014 |
Conversion to sirolimus ameliorates cyclosporine-induced nephropathy in the rat: focus on serum, urine, gene, and protein renal expression biomarkers.
Topics: Animals; Biomarkers; Cell Proliferation; Collagen; Cyclosporine; Gene Expression Regulation; Immunohistochemistry; Inflammation; Kidney; Kidney Diseases; Male; Neovascularization, Physiologic; Proteins; Rats, Wistar; RNA, Messenger; Sirolimus | 2014 |
Melatonin synergized with cyclosporine A improves cardiac allograft survival by suppressing inflammation and apoptosis.
Topics: Allografts; Animals; Apoptosis; bcl-2-Associated X Protein; Cyclosporine; Drug Synergism; Graft Survival; Heart; Heart Transplantation; Immunosuppressive Agents; Inflammation; Interleukin-1beta; Interleukin-2; Male; Melatonin; Muscle Cells; Neoplasm Proteins; Nucleocytoplasmic Transport Proteins; Rats; Rats, Sprague-Dawley; Rats, Wistar; Tumor Necrosis Factor-alpha | 2014 |
Cyclosporine A regulates pro-inflammatory cytokine production in ulcerative colitis.
Topics: Adolescent; Adult; Aged; Apoptosis; Case-Control Studies; Caspase 8; CD4-Positive T-Lymphocytes; Cell Survival; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Cytokines; Flow Cytometry; Gene Expression Regulation; Humans; Inflammation; Interleukin-13; Leukocytes, Mononuclear; Microscopy, Fluorescence; Middle Aged; T-Lymphocytes; Young Adult | 2015 |
Evolution of serum atherogenic risk in liver transplant recipients: Role of lipoproteins and metabolic and inflammatory markers.
Topics: Aged; Atherosclerosis; Biomarkers; Body Mass Index; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Cyclosporine; Female; Humans; Immunosuppression Therapy; Inflammation; Lipoproteins; Liver Cirrhosis; Liver Failure; Liver Transplantation; Male; Middle Aged; Prospective Studies; Risk; Tacrolimus; Transplant Recipients | 2015 |
Glucocorticoid-resistant Th17 cells are selectively attenuated by cyclosporine A.
Topics: Animals; Autoimmunity; Calcineurin; Calcineurin Inhibitors; CD4-Positive T-Lymphocytes; Cell Nucleus; Cell Proliferation; Cyclosporine; Disease Models, Animal; Glucocorticoids; Humans; Inflammation; Interferon-gamma; Interleukin-17; Mice; Mice, Transgenic; Phenotype; Steroids; Th17 Cells | 2015 |
1,25(OH)2D3 Promotes the Efficacy of CD28 Costimulation Blockade by Abatacept.
Topics: Abatacept; Animals; Apoptosis; Arthritis, Rheumatoid; Calcitriol; CD28 Antigens; Cell Line; Cell Proliferation; CHO Cells; Cricetulus; Cyclosporine; Immunosuppressive Agents; Inflammation; Lymphocyte Activation; Receptors, Antigen, T-Cell; T-Lymphocytes | 2015 |
Cyclosporine A Treatment Inhibits Abcc6-Dependent Cardiac Necrosis and Calcification following Coxsackievirus B3 Infection in Mice.
Topics: Animals; ATP-Binding Cassette Transporters; Calcinosis; Coxsackievirus Infections; Cyclophilins; Cyclosporine; Enterovirus B, Human; Female; Immunosuppressive Agents; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Electron, Transmission; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Multidrug Resistance-Associated Proteins; Myocarditis; Necrosis; Peptidyl-Prolyl Isomerase F | 2015 |
Cyclosporin A significantly improves preeclampsia signs and suppresses inflammation in a rat model.
Topics: Analysis of Variance; Animals; Blood Pressure; Cyclosporine; Female; Fetal Weight; Gestational Age; Immunosuppressive Agents; Inflammation; Interferon-gamma; Interleukin-17; Interleukin-6; Lipopolysaccharides; Male; Pre-Eclampsia; Pregnancy; Random Allocation; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2016 |
Biopharmaceutical Evaluation of Novel Cyclosporine A Nano-matrix Particles for Inhalation.
Topics: Administration, Inhalation; Animals; Biomarkers; Chemistry, Pharmaceutical; Cyclosporine; Inflammation; Male; Mannitol; Nanoparticles; Particle Size; Rats; Rats, Sprague-Dawley | 2016 |
Calcineurin inhibitors cyclosporine A and tacrolimus induce vascular inflammation and endothelial activation through TLR4 signaling.
Topics: Animals; Aorta; Calcineurin; Calcineurin Inhibitors; Cell Line; Cyclosporine; Endothelial Cells; Inflammation; Intercellular Adhesion Molecule-1; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Myeloid Differentiation Factor 88; Reactive Oxygen Species; Signal Transduction; Tacrolimus; Toll-Like Receptor 4; Vascular Cell Adhesion Molecule-1 | 2016 |
TLR4-mediated inflammation is a key pathogenic event leading to kidney damage and fibrosis in cyclosporine nephrotoxicity.
Topics: Animals; Cyclosporine; Cytokines; Fibrosis; HMGB1 Protein; Immunosuppressive Agents; Inflammation; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Rats; Sulfonamides; Toll-Like Receptor 4 | 2017 |
Nanoliposome containing cyclosporine A reduced neuroinflammation responses and improved neurological activities in cerebral ischemia/reperfusion in rat.
Topics: Animals; Brain Ischemia; Cyclosporine; Disease Models, Animal; Infarction, Middle Cerebral Artery; Inflammation; Liposomes; Male; Nanoparticles; Neuroprotective Agents; Peroxidase; Rats; Rats, Wistar; Reperfusion Injury; Stroke; Time Factors; Tumor Necrosis Factor-alpha | 2017 |
Cyclosporine A inhibits TGF-β2-induced myofibroblasts of primary cultured human pterygium fibroblasts.
Topics: Actins; Cell Differentiation; Cells, Cultured; Cyclosporine; Female; Fibroblasts; Fibronectins; Humans; Immunosuppressive Agents; Inflammation; Laminin; Male; Microscopy, Fluorescence; Muscle, Smooth; Myofibroblasts; Oligonucleotides; Pterygium; Signal Transduction; Software; Transforming Growth Factor beta2 | 2017 |
Cyclosporine in ocular surface inflammation.
Topics: Administration, Topical; Cyclosporine; Humans; Immunosuppressive Agents; Inflammation; Ophthalmic Solutions | 2017 |
The inflammatory state provokes sexual dimorphism in left ventricular and electrocardiographic effects of chronic cyclosporine in rats.
Topics: Animals; Blood Pressure; Cyclosporine; Electrocardiography; Female; Heart Ventricles; Hemodynamics; Inflammation; Lipid Metabolism; Male; Rats; Sex Characteristics; Ventricular Function | 2017 |
A novel gingival overgrowth mouse model induced by the combination of CsA and ligature-induced inflammation.
Topics: Animals; Cyclosporine; Disease Models, Animal; Female; Gingival Overgrowth; Inflammation; Ligation; Male; Mice; Mice, Inbred C57BL | 2017 |
Tacrolimus (FK506) and cyclosporin A reduce macrophage recruitment to the rat brain injured at perinatal and early postnatal periods.
Topics: Age Factors; Animals; Animals, Newborn; Autoradiography; Brain; Brain Injuries; Cell Count; Cell Proliferation; Cyclosporine; Dose-Response Relationship, Drug; Immunosuppressive Agents; Inflammation; Macrophage Activation; Macrophages; Male; Neurons; Rats; Rats, Wistar; Statistics, Nonparametric; Tacrolimus | 2009 |
Donor preconditioning with a calcineurin inhibitor improves outcome in rat syngeneic kidney transplantation.
Topics: Animals; Creatinine; Cyclosporine; Immunosuppressive Agents; Inflammation; Kidney Transplantation; Kidney Tubules; Models, Animal; Necrosis; Rats; Rats, Inbred F344; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Transplantation, Isogeneic; Treatment Outcome | 2009 |
Intestinal perforation secondary to haematopoietic stem cell transplant associated thrombotic microangiopathy.
Topics: Adult; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Inflammation; Intestinal Perforation; Lymphoma, Follicular; Male; Microcirculation; Purpura, Thrombotic Thrombocytopenic; Transplantation Conditioning | 2009 |
The effect of topical cyclosporine A treatment on corneal thickness in patients with trachomatous dry eye.
Topics: Administration, Topical; Aged; Aged, 80 and over; Cornea; Cyclosporine; Dry Eye Syndromes; Female; Humans; Immunosuppressive Agents; Inflammation; Male; Middle Aged; Trachoma | 2009 |
Protective effects of Mizoribine on Cyclosporine A nephropathy in rats.
Topics: Animals; Anti-Inflammatory Agents; Body Weight; Cyclosporine; Disease Progression; Fibrosis; Immunohistochemistry; Immunosuppressive Agents; Inflammation; Kidney; Kidney Diseases; Male; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Ribonucleosides | 2009 |
The VEGF-induced transcriptional response comprises gene clusters at the crossroad of angiogenesis and inflammation.
Topics: Calcineurin; Cyclosporine; Endothelial Cells; Gene Expression Regulation; Humans; Inflammation; Interleukin-1; Models, Genetic; Multigene Family; Neovascularization, Pathologic; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; Transcription, Genetic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2009 |
The upregulation of heat shock protein 47 in human gingival fibroblasts stimulated with cyclosporine A.
Topics: Aggregatibacter actinomycetemcomitans; Blotting, Western; Butadienes; Cells, Cultured; Cyclosporine; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Inhibitors; Epithelial Cells; Fibroblasts; Gingiva; Gingival Overgrowth; HSP47 Heat-Shock Proteins; Humans; Immunohistochemistry; Immunosuppressive Agents; Inflammation; Interleukin-1alpha; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Nitriles; Up-Regulation | 2010 |
Cyclosporine for ocular inflammatory diseases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Cyclosporine; Female; Humans; Immunosuppressive Agents; Inflammation; Male; Middle Aged; Pemphigoid, Benign Mucous Membrane; Retrospective Studies; Scleritis; Treatment Outcome; Uveitis; Young Adult | 2010 |
Paricalcitol attenuates cyclosporine-induced kidney injury in rats.
Topics: Animals; Apoptosis; Cyclosporine; Ergocalciferols; Fibrosis; Inflammation; Kidney Diseases; Protective Agents; Rats; Signal Transduction; Treatment Outcome | 2010 |
Association between chronic liver and colon inflammation during the development of murine syngeneic graft-versus-host disease.
Topics: Animals; Bone Marrow Transplantation; Chronic Disease; Colonic Diseases; Cyclosporine; Disease Models, Animal; Female; Graft vs Host Disease; Immunosuppressive Agents; Inflammation; Liver Diseases; Mice; Mice, Inbred C3H; Toll-Like Receptors; Transplantation, Isogeneic | 2010 |
Effects of immunomodulatory drugs on plasma inflammatory markers in a rabbit model of atherosclerosis.
Topics: Animals; Atherosclerosis; Atorvastatin; Biomarkers; C-Reactive Protein; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Cyclosporine; Heptanoic Acids; Immunologic Factors; Inflammation; Interferon-gamma; Interleukin-6; Male; Plasma; Pyrroles; Rabbits; Tacrolimus; Triglycerides | 2011 |
Pro-inflammatory activities induced by CyPA-EMMPRIN interaction in monocytes.
Topics: Basigin; Cell Line; Cell Movement; Cyclophilin A; Cyclosporine; Extracellular Matrix; Extracellular Signal-Regulated MAP Kinases; Humans; Inflammation; Interleukin-6; Macrophages; Matrix Metalloproteinase 9; Monocytes; NF-kappa B; Signal Transduction | 2010 |
Rapamycin prevents interstitial fibrosis in renal allografts through decreasing angiogenesis and inflammation.
Topics: Adult; Antigens, CD34; Biopsy; Cell Proliferation; Cyclosporine; Female; Fibrosis; Graft Survival; Humans; Immunosuppressive Agents; Inflammation; Kidney Transplantation; Lymphocytes; Macrophages; Male; Neovascularization, Pathologic; Sirolimus; Transplantation, Homologous | 2011 |
Immunosuppressant cytoprotection correlates with HMGB1 suppression in primary astrocyte cultures exposed to combined oxygen-glucose deprivation.
Topics: Animals; Astrocytes; Cell Hypoxia; Cells, Cultured; Cyclosporine; Dose-Response Relationship, Drug; Glucose; HMGB1 Protein; Immunosuppressive Agents; Inflammation; Inflammation Mediators; Ischemia; Necrosis; Oxidative Stress; Rats; Rats, Wistar; Sirolimus; Tacrolimus | 2011 |
Combination of cyclosporine and erythropoietin improves brain infarct size and neurological function in rats after ischemic stroke.
Topics: Animals; Apoptosis; Aquaporin 4; Brain Infarction; Cell Nucleus; Cyclosporine; Cytochromes c; Drug Therapy, Combination; Erythropoietin; Gene Expression Regulation; Glial Fibrillary Acidic Protein; In Situ Nick-End Labeling; Inflammation; Male; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rats; Rats, Sprague-Dawley; Recovery of Function; RNA-Binding Proteins; RNA, Messenger; Stroke; Transcription Factors | 2011 |
Angiotensin II signalling and calcineurin in cardiac fibroblasts: differential effects of calcineurin inhibitors FK506 and cyclosporine A.
Topics: Angiotensin II; Animals; Calcineurin; Cell Proliferation; Cyclosporine; Fibroblasts; Immunosuppressive Agents; Inflammation; Mitogen-Activated Protein Kinases; Myocardium; Phosphorylation; Rats; Rats, Inbred WKY; Signal Transduction; Tacrolimus | 2012 |
Long term stabilization of expanding aortic aneurysms by a short course of cyclosporine A through transforming growth factor-beta induction.
Topics: Animals; Aortic Aneurysm, Abdominal; Calcium Chloride; Cyclosporine; Disease Models, Animal; Elastin; Humans; Inflammation; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Pancreatic Elastase; Rats; Rats, Wistar; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta | 2011 |
The effects of immunosuppressants on vascular function, systemic oxidative stress and inflammation in rats.
Topics: Animals; Aorta; Biomarkers; Cyclosporine; Cytokines; Endothelium, Vascular; Everolimus; Immunosuppressive Agents; Inflammation; Male; Muscle, Smooth; Oxidative Stress; Rats; Rats, Wistar; Sirolimus; Tacrolimus | 2012 |
Three cases of idiopathic sterile pyogranulomatous inflammation of epidural fat in Miniature Dachshunds.
Topics: Adipose Tissue; Animals; Cyclosporine; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Inflammation; Laminectomy; Male; Prednisolone | 2012 |
Effects of immunosuppression by cyclosporine A on allogenic uterine transplant in the rat.
Topics: Animals; Antigens, CD; CD8-Positive T-Lymphocytes; Cyclosporine; Female; Galectin 1; Graft Rejection; Gynecologic Surgical Procedures; Immunosuppression Therapy; Inflammation; Interleukin-15; Interleukin-1alpha; Leukemia Inhibitory Factor; Rats; Rats, Inbred BN; Rats, Inbred Lew; RNA, Messenger; Tissue Donors; Transplantation, Homologous; Uterus | 2012 |
Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases, and inflammation in cyclosporine A-induced gingival enlargement: a pilot in vitro study using a three-dimensional model of the human oral mucosa.
Topics: Analysis of Variance; Cells, Cultured; Cyclosporine; Extracellular Matrix Proteins; Gingiva; Gingival Overgrowth; Humans; Inflammation; Intercellular Signaling Peptides and Proteins; Matrix Metalloproteinase 1; Matrix Metalloproteinases; Models, Anatomic; Mouth Mucosa; Pilot Projects; Statistics, Nonparametric; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinases | 2013 |
Critical role of VEGF-C/VEGFR-3 signaling in innate and adaptive immune responses in experimental obliterative bronchiolitis.
Topics: Adaptive Immunity; Animals; Bronchiolitis Obliterans; Chemotaxis; Cyclosporine; Dendritic Cells; Dose-Response Relationship, Drug; Down-Regulation; Epithelial Cells; Epithelium; Graft Rejection; Immunity, Innate; Immunoglobulins; Inflammation; Lymphangiogenesis; Macrophages; Neutrophils; Rats; Signal Transduction; Th17 Cells; Trachea; Transplantation, Homologous; Up-Regulation; Vascular Endothelial Growth Factor C; Vascular Endothelial Growth Factor Receptor-3 | 2012 |
Extracellular factors and immunosuppressive drugs influencing insulin secretion of murine islets.
Topics: Animals; Apoptosis; Cyclosporine; Extracellular Matrix; Fibronectins; Glucose; Humans; Immunosuppressive Agents; Inflammation; Insulin; Insulin Secretion; Interleukin-1beta; Islets of Langerhans; Islets of Langerhans Transplantation; Kupffer Cells; Laminin; Mice; Mice, Inbred C57BL; Tacrolimus; Tumor Necrosis Factor-alpha | 2012 |
Humanized mouse model of skin inflammation is characterized by disturbed keratinocyte differentiation and influx of IL-17A producing T cells.
Topics: Animals; Antigens, Differentiation, T-Lymphocyte; beta-Defensins; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Differentiation; Cyclosporine; Disease Models, Animal; Elafin; Gene Expression Regulation; Humans; Inflammation; Injections, Intraperitoneal; Interleukin-17; Keratinocytes; Keratins; Ki-67 Antigen; L-Selectin; Membrane Glycoproteins; Mice; Mice, SCID; Sirolimus; Skin; Skin Transplantation; Transplantation, Heterologous | 2012 |
Ursolic acid, a potential PPARγ agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma.
Topics: Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Cell Count; Cell Line; Cyclosporine; Disease Models, Animal; Down-Regulation; Eosinophils; Female; GATA3 Transcription Factor; Hypersensitivity; Immunoglobulin E; Inflammation; Interleukin-13; Interleukin-17; Interleukin-5; Interleukins; Lung; Macrophages; Mice; Mice, Inbred BALB C; Ovalbumin; PPAR gamma; RNA, Messenger; STAT6 Transcription Factor; Th2 Cells; Triterpenes; Ursolic Acid | 2013 |
Cyclosporine A normalizes mitochondrial coupling, reactive oxygen species production, and inflammation and partially restores skeletal muscle maximal oxidative capacity in experimental aortic cross-clamping.
Topics: Animals; Aorta; Blotting, Western; Calcium; Constriction; Cyclophilins; Cyclosporine; Disease Models, Animal; Electron Transport Chain Complex Proteins; Energy Metabolism; Immunohistochemistry; Inflammation; Injections, Intraperitoneal; Macrophages; Male; Mitochondria, Heart; Mitochondria, Muscle; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Muscle, Skeletal; Oxidative Stress; Peptidyl-Prolyl Isomerase F; Rats; Rats, Wistar; Reactive Oxygen Species; Reperfusion Injury; Time Factors | 2013 |
Inflammatory cells induce neointimal growth in a rat arterial autograft model.
Topics: Animals; Arteries; Cell Adhesion; Cyclosporine; Female; Immunohistochemistry; Immunosuppressive Agents; Inflammation; Macrophages; Neutrophils; Rats; Rats, Sprague-Dawley; T-Lymphocytes; Time Factors; Transplantation, Autologous; Tunica Intima | 2002 |
Colchicine suppresses osteopontin expression and inflammatory cell infiltration in chronic cyclosporine nephrotoxicity.
Topics: Animals; Colchicine; Cyclosporine; Fibrosis; Gene Expression; Immunosuppressive Agents; Inflammation; Kidney; Macrophages; Male; Osteopontin; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sialoglycoproteins | 2002 |
Regulation and phenotype of an innate Th1 cell: role of cytokines and the p38 kinase pathway.
Topics: Animals; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Apoptosis; Cell Division; Cell Line; Chronic Disease; Cyclosporine; Cytokines; Enzyme Inhibitors; Epitopes, T-Lymphocyte; Immunity, Innate; Immunophenotyping; Inflammation; Interferon-gamma; Interleukin-12; Interleukin-18; Lectins, C-Type; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Receptors, Antigen, T-Cell; Receptors, Interleukin-2; Th1 Cells | 2003 |
Inflammation: a unifying theory for the origin of dry eye syndrome.
Topics: Aged; Anti-Inflammatory Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclosporine; Humans; Inflammation; Keratoconjunctivitis Sicca; Lacrimal Apparatus; Middle Aged; Tears; United States | 2003 |
Additional evidence of acute anti-inflammatory effects of cyclosporin A in a murine model of pleurisy.
Topics: Animals; Anti-Inflammatory Agents; Carrageenan; Chemotaxis, Leukocyte; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Immunologic; Inflammation; Leukocytes; Mice; Nitrates; Nitrites; Peroxidase; Pleurisy | 2004 |
Reduction of beta-endorphin-containing immune cells in inflamed paw tissue corresponds with a reduction in immune-derived antinociception: reversible by donor activated lymphocytes.
Topics: Analgesia; Animals; beta-Endorphin; CD4 Lymphocyte Count; Concanavalin A; Cyclosporine; Dose-Response Relationship, Drug; Fluorescent Antibody Technique; Foot; Freund's Adjuvant; Immunosuppressive Agents; Inflammation; Lymphocyte Activation; Lymphocytes; Male; Pain Threshold; Radioimmunoassay; Rats; Rats, Wistar | 2004 |
Acute polymyositis following renal transplantation.
Topics: Acute Disease; Anti-Inflammatory Agents; Antigens; Creatine Kinase; Cyclosporine; Electrolytes; Electromyography; HLA Antigens; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Inflammation; Kidney Transplantation; Male; Middle Aged; Muscles; Mycophenolic Acid; Myositis; Polymyositis; Prednisolone; Time Factors | 2004 |
Desensitization of the permeability transition pore by cyclosporin a prevents activation of the mitochondrial apoptotic pathway and liver damage by tumor necrosis factor-alpha.
Topics: Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; Blotting, Western; Calcium; Caspase 3; Caspases; Cell Death; Cell Nucleus; Cyclosporine; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Escherichia coli; Galactosamine; In Situ Nick-End Labeling; Inflammation; Lipopolysaccharides; Liver; Male; Mitochondria; Mitochondria, Liver; Models, Biological; Permeability; Rats; Rats, Wistar; Time Factors; Tumor Necrosis Factor-alpha | 2004 |
A cyclosporine-sensitive psoriasis-like disease produced in Tie2 transgenic mice.
Topics: Angiopoietins; Animals; Blotting, Western; Cell Line; Cyclosporine; Doxycycline; Enzyme-Linked Immunosorbent Assay; Epidermis; Gene Expression Regulation; Genotype; Humans; Immunohistochemistry; Immunoprecipitation; Immunosuppressive Agents; Inflammation; Keratinocytes; Lac Operon; Lectins; Mice; Mice, Transgenic; Models, Genetic; Phenotype; Psoriasis; Receptor, TIE-2; Signal Transduction; Skin; Tetracycline; Time Factors; Transgenes; Vascular Endothelial Growth Factor A | 2005 |
Hierarchical change in antioxidant enzyme gene expression and activity in acute cardiac rejection: role of inducible nitric oxide synthase.
Topics: Animals; Antioxidants; Blotting, Western; Catalase; Cyclosporine; Densitometry; Down-Regulation; Enzyme Inhibitors; Gene Expression Regulation; Glutathione Peroxidase; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Inflammation; Lysine; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Protein Processing, Post-Translational; Rats; Rats, Inbred Lew; Rats, Inbred WF; Reactive Nitrogen Species; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA; Superoxide Dismutase; Time Factors; Transcription, Genetic | 2005 |
Anti-exudative effects of opioid receptor agonists in a rat model of carrageenan-induced acute inflammation of the paw.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Benzamides; Capsaicin; Carrageenan; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Enkephalin, D-Penicillamine (2,5)-; Extravasation of Diagnostic and Therapeutic Materials; Fentanyl; Hindlimb; Histamine Antagonists; Inflammation; Male; Morphine; Narcotic Antagonists; Oxidopamine; p-Methoxy-N-methylphenethylamine; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2005 |
Calcineurin triggers reactive/inflammatory processes in astrocytes and is upregulated in aging and Alzheimer's models.
Topics: Adenoviridae; Age Factors; Aging; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Astrocytes; Calcineurin; Cells, Cultured; Cyclosporine; Disease Models, Animal; Enzyme Inhibitors; Fluorescent Antibody Technique; Genetic Vectors; Glial Fibrillary Acidic Protein; Immunohistochemistry; Inflammation; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microarray Analysis; Presenilin-1; Rats; Rats, Inbred F344; Up-Regulation | 2005 |
Oxidative stress and 8-iso-prostaglandin F(2alpha) induce ectodomain shedding of CD163 and release of tumor necrosis factor-alpha from human monocytes.
Topics: Androstadienes; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Calcium; Chelating Agents; Cyclosporine; Dinoprost; Egtazic Acid; Fluticasone; Humans; Hydrogen Peroxide; Inflammation; Monocytes; Oxidative Stress; Reactive Oxygen Species; Receptors, Cell Surface; S-Nitroso-N-Acetylpenicillamine; Tumor Necrosis Factor-alpha | 2005 |
Combined effects of losartan and pravastatin on interstitial inflammation and fibrosis in chronic cyclosporine-induced nephropathy.
Topics: Animals; C-Reactive Protein; Cyclosporine; Disease Models, Animal; Fibrosis; Inflammation; Kidney; Kidney Diseases; Losartan; Male; Pravastatin; Rats; Rats, Sprague-Dawley | 2005 |
Inflammatory response to mucosal barrier injury after myeloablative therapy in allogeneic stem cell transplant recipients.
Topics: Adult; Aged; Bacteremia; Biomarkers; C-Reactive Protein; Cyclosporine; Female; Humans; Immunosuppressive Agents; Inflammation; Lactulose; Lymphocyte Depletion; Male; Middle Aged; Mouth Mucosa; Permeability; Rhamnose; Stem Cell Transplantation; T-Lymphocytes | 2005 |
Transcriptional regulation of ADAMTS13.
Topics: ADAM Proteins; ADAMTS13 Protein; Adrenal Cortex Hormones; Anti-Bacterial Agents; Binding Sites; Cell Line; Cyclosporine; DNA, Complementary; Doxycycline; Endothelium, Vascular; Exons; Gene Expression Regulation; Humans; Immunosuppressive Agents; Inflammation; Interleukin-1; Interleukin-6; Liver; Metalloendopeptidases; Promoter Regions, Genetic; Purpura, Thrombotic Thrombocytopenic; Reverse Transcriptase Polymerase Chain Reaction; RNA; Steroids; Transcription, Genetic; Tumor Necrosis Factor-alpha; von Willebrand Factor | 2005 |
Reciprocal role of cyclins and cyclin kinase inhibitor p21WAF1/CIP1 on lymphocyte proliferation, allo-immune activation and inflammation.
Topics: Animals; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cyclosporine; Cytokines; Gene Expression Profiling; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Inflammation; Interleukin-2; Jurkat Cells; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Lymphocytes; Rats; Rats, Inbred Lew; Rats, Inbred WF; Recombinant Fusion Proteins; RNA, Messenger; Transplantation, Heterotopic; Transplantation, Homologous | 2005 |
Prostaglandin E2 promotes degranulation-independent release of MCP-1 from mast cells.
Topics: Angiogenesis Inducing Agents; Animals; Anti-Inflammatory Agents; Cell Degranulation; Cells, Cultured; Chemokine CCL2; Cyclosporine; Dexamethasone; Dinoprostone; Dose-Response Relationship, Drug; Drug Antagonism; Immunosuppressive Agents; Inflammation; Mast Cells; Mice; Neovascularization, Pathologic; Oxytocics; Secretory Vesicles | 2006 |
Effects of cyclosporine A in hyperzincaemia and hypercalprotectinaemia.
Topics: Child; Cyclosporine; Cytokines; Female; Hepatomegaly; Humans; Immunosuppressive Agents; Inflammation; Leukocyte L1 Antigen Complex; Metabolism, Inborn Errors; Metal Metabolism, Inborn Errors; Pyoderma; Splenomegaly; Zinc | 2006 |
[Repetitive instillation of 0.1% cyclosporin A eye drops induces miosis and anterior chamber inflammation-like reactions in monkey eyes].
Topics: Animals; Anterior Chamber; Cyclosporine; Haplorhini; Inflammation; Male; Miosis; Ophthalmic Solutions; Rabbits | 2006 |
Pharmacological profile of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on acute and chronic inflammation models.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acute Disease; Animals; Anti-Inflammatory Agents; Carrageenan; Chronic Disease; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclic Nucleotide Phosphodiesterases, Type 7; Cyclosporine; Dermatitis, Contact; Edema; Erythrocytes; Fumarates; Hypersensitivity, Delayed; Immunosuppressive Agents; Indoles; Inflammation; Male; Mice; Mice, Inbred BALB C; Peritonitis; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Sheep; Sulfonamides; Toluene 2,4-Diisocyanate; Zymosan | 2006 |
Epstein-Barr virus-associated B cell lymphoproliferative disease in a child with neonatal-onset multisystem inflammatory disease.
Topics: Antirheumatic Agents; B-Lymphocytes; Cyclosporine; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Infant; Infant, Newborn; Inflammation; Lymphoproliferative Disorders; Rheumatic Diseases; Syndrome | 2006 |
The up-regulation of type I plasminogen activator inhibitor in human gingival fibroblasts stimulated with cyclosporin A.
Topics: Cells, Cultured; Coloring Agents; Cyclosporine; Cytoplasm; Endothelial Cells; Fibroblasts; Gingiva; Gingival Overgrowth; Humans; Immunosuppressive Agents; Inflammation; Plasminogen Activator Inhibitor 1; Time Factors; Up-Regulation | 2007 |
Demographic, pharmacologic, and periodontal variables for gingival overgrowth in subjects medicated with cyclosporin in the absence of calcium channel blockers.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Calcium Channel Blockers; Chi-Square Distribution; Cyclosporine; Female; Gingival Overgrowth; Humans; Immunosuppressive Agents; Inflammation; Kidney Transplantation; Male; Prednisolone; Regression Analysis; Statistics, Nonparametric; Time Factors | 2007 |
CCR5 blockade modulates inflammation and alloimmunity in primates.
Topics: Animals; Antibody Formation; Autoimmunity; CCR5 Receptor Antagonists; Cyclosporine; Disease Models, Animal; Graft Survival; Heart Transplantation; HIV Infections; Humans; Immunosuppressive Agents; Inflammation; Isoantibodies; Kidney Transplantation; Macaca fascicularis; Macrophages; Male; Pyrazoles; Stress, Physiological; T-Lymphocytes; Transplantation Tolerance; Transplantation, Homologous; Valine; Vascular Diseases | 2007 |
Clinically relevant immunosuppressants influence UVB-induced tumor size through effects on inflammation and angiogenesis.
Topics: Animals; Blood Vessels; Carcinoma, Squamous Cell; Cyclosporine; Disease Models, Animal; Drug Therapy, Combination; Female; Immunosuppressive Agents; Inflammation; Mice; Mice, Hairless; Mycophenolic Acid; Neoplasms, Radiation-Induced; Neovascularization, Pathologic; Sirolimus; Skin Neoplasms; Tacrolimus; Ultraviolet Rays | 2007 |
Methotrexate and cyclosporine treatments modify the activities of dipeptidyl peptidase IV and prolyl oligopeptidase in murine macrophages.
Topics: Animals; Cyclosporine; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Drug Therapy, Combination; Enzyme Inhibitors; Immunosuppressive Agents; Inflammation; Macrophages, Peritoneal; Male; Methotrexate; Mice; Pain; Prolyl Oligopeptidases; Serine Endopeptidases | 2008 |
Influence of anti-inflammatory treatments on experimental infection of rats with Fasciola hepatica: changes in serum levels of inflammatory markers during the early stages of fasciolosis.
Topics: Acute-Phase Proteins; Analysis of Variance; Animals; Antibodies, Helminth; Antibody Formation; Antigens, Helminth; Aspirin; Biomarkers; Complement C3; Cyclosporine; Dexamethasone; Fasciola hepatica; Fascioliasis; Female; Fibrinogen; Indomethacin; Inflammation; Leukocyte Count; Male; Platelet Count; Rats; Rats, Wistar; Time Factors | 1994 |
Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression.
Topics: Agranulocytosis; Animals; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Chronic Disease; Cyclosporine; Female; Immune Tolerance; Immunosuppressive Agents; Inflammation; Lung; Methylprednisolone; Opportunistic Infections; Rabbits | 1995 |
CsA levels in the early posttransplant period--predictive of chronic rejection in liver transplantation?
Topics: Adult; Age Factors; Azathioprine; Child; Cyclosporine; Drug Monitoring; Drug Therapy, Combination; Female; Graft Rejection; Humans; Inflammation; Liver Transplantation; Male; Middle Aged; Predictive Value of Tests; Prednisolone; Probability; Retrospective Studies; Risk Factors; Tissue Donors | 1995 |
Dexamethasone or cyclosporin A suppress mast cell-leukocyte cytokine cascades. Multiple mechanisms of inhibition of IgE- and mast cell-dependent cutaneous inflammation in the mouse.
Topics: Animals; Chemotaxis, Leukocyte; Cyclosporine; Dexamethasone; Immunoglobulin E; Inflammation; Mast Cells; Mice; Neutrophils; Skin; Tumor Necrosis Factor-alpha | 1995 |
Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue.
Topics: Analysis of Variance; Animals; Antibodies; beta-Endorphin; Corticotropin-Releasing Hormone; Cyclosporine; Dose-Response Relationship, Drug; Dynorphins; Endorphins; Enkephalin, Leucine; Enkephalin, Methionine; Humans; Inflammation; Injections; Interleukin-1; Male; Naloxone; Pain; Rats; Rats, Wistar; Recombinant Proteins; Regression Analysis; Somatostatin | 1994 |
Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver.
Topics: Adenoviridae; Adenovirus E2 Proteins; Animals; beta-Galactosidase; CD8 Antigens; Cyclosporine; Escherichia coli; Gene Deletion; Gene Expression; Genes, Viral; Genetic Therapy; Genetic Vectors; Humans; Immunohistochemistry; Inflammation; Liver; Mice; Mice, Transgenic | 1994 |
Thy1+ bone marrow cells regulate the induction of murine syngeneic graft-versus-host disease.
Topics: Animals; Antigens, Surface; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Inflammation; Liver; Lymphocyte Depletion; Membrane Glycoproteins; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Splenomegaly; T-Lymphocytes; Thy-1 Antigens; Tongue; Transplantation, Homologous; Transplantation, Isogeneic | 1993 |
Interleukin-1 (IL-1) production in a mouse tissue chamber model of inflammation. II. Identification of (tissue) macrophages as the IL-1 producing cells and the effect of anti-inflammatory drugs.
Topics: Animals; Cyclosporine; Diffusion Chambers, Culture; Dinoprostone; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Granuloma; Indomethacin; Inflammation; Interleukin-1; Macrophages; Mice; Pertussis Vaccine; Polymerase Chain Reaction; Prednisolone; RNA, Messenger; Zymosan | 1993 |
Abnormal T-cell costimulation by proteins of the extracellular matrix in human renal allografting.
Topics: Arteritis; Azathioprine; Collagen; Cyclosporine; Endothelium, Vascular; Extracellular Matrix Proteins; Fibronectins; Graft Rejection; Humans; Inflammation; Kidney Transplantation; Lymphocyte Activation; Postoperative Complications; Prednisone; Receptors, Cell Surface; Renal Artery; T-Lymphocyte Subsets | 1993 |
Peripheral mechanisms of opioid antinociception in inflammation: involvement of cytokines.
Topics: Amino Acid Sequence; Animals; beta-Endorphin; Cyclosporine; Cytokines; Inflammation; Interleukin-6; Male; Molecular Sequence Data; Narcotic Antagonists; Pain; Peripheral Nervous System; Rats; Rats, Wistar; Receptors, Opioid; Tumor Necrosis Factor-alpha | 1993 |
Effect of immunosuppression on chronic rejection in the rat aortic allograft model.
Topics: Animals; Aorta, Thoracic; Chronic Disease; Cyclosporine; Immunosuppressive Agents; Inflammation; Muscle, Smooth, Vascular; Necrosis; Polyenes; Rats; Rats, Inbred Lew; Rats, Inbred WF; Sirolimus; Transplantation, Homologous; Transplantation, Isogeneic | 1993 |
Suppression of local and systemic responses in streptococcal cell wall-induced acute inflammation of the air pouch by cyclosporine A. Comparison with the effects of two anti-inflammatory bis-benzimidazoles.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzimidazoles; Bone Marrow; Cell Wall; Cyclosporine; Female; Hematopoietic System; Hemoglobins; Hyperplasia; Inflammation; Injections, Subcutaneous; Leukocytes; Macrophages; Rats; Rats, Inbred Lew; Spleen; Streptococcus pyogenes | 1993 |
Treatment of chronic inflammatory demyelinating polyneuropathy with cyclosporin-A.
Topics: Adolescent; Adult; Aged; Cyclosporine; Demyelinating Diseases; Female; Humans; Inflammation; Male; Middle Aged; Prednisone; Time Factors | 1996 |
Lung lymphocyte elimination by apoptosis in the murine response to intratracheal particulate antigen.
Topics: Animals; Antibodies, Monoclonal; Antigens; Apoptosis; Bronchoalveolar Lavage Fluid; CD3 Complex; CD4 Antigens; CD8 Antigens; Cyclosporine; DNA; DNA Fragmentation; Electrophoresis, Agar Gel; Erythrocytes; fas Receptor; Female; Flow Cytometry; Immunosuppressive Agents; Inflammation; Leukocyte Common Antigens; Lung; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred MRL lpr; Mice, Mutant Strains; Phosphatidylserines; Receptors, Cell Surface; Sheep; T-Lymphocytes; Thy-1 Antigens | 1997 |
[Pathogenesis and therapy of inflammatory dermatoses. Cyclosporin, an advance in the therapy of psoriasis].
Topics: Anti-Inflammatory Agents; Cyclosporine; Dermatitis; Humans; Inflammation; Psoriasis | 1995 |
Cyclosporin A-sensitive calcium signaling represses NFkappaB activation in human bronchial epithelial cells and enhances NFkappaB activation in Jurkat T-cells.
Topics: Base Sequence; Bronchi; Calcium; Cell Line, Transformed; Cyclosporine; Epithelium; Genes, Reporter; Humans; Inflammation; Ionomycin; Jurkat Cells; Luciferases; NF-kappa B; Oligonucleotide Probes; Signal Transduction; Tacrolimus; Tetradecanoylphorbol Acetate; Transcriptional Activation; Transfection | 1997 |
Effects of increased ICAM-1 on reperfusion injury and chronic graft vascular disease.
Topics: Animals; Antibodies, Monoclonal; Chronic Disease; Coronary Disease; Cyclosporine; Disease Models, Animal; Heart Transplantation; Inflammation; Intercellular Adhesion Molecule-1; Lipopolysaccharides; Male; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Inbred ACI; Rats, Inbred Strains; RNA, Messenger; Transplantation, Heterotopic; Up-Regulation | 1997 |
An experimental model of chronic kidney allograft rejection under triple-drug treatment in the rat.
Topics: Animals; Azathioprine; Biopsy, Needle; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Immunosuppressive Agents; Inflammation; Kidney Transplantation; Methylprednisolone; Rats; Rats, Inbred BN; Rats, Inbred Strains; Transplantation, Homologous; Transplantation, Isogeneic | 1997 |
Effect of immunosuppression on obliterative lesions in a heterotopic large-animal bronchial allograft model.
Topics: Animals; Azathioprine; Bronchi; Bronchiolitis Obliterans; Cartilage; Cyclosporine; Drug Therapy, Combination; Fibrosis; Immunosuppressive Agents; Inflammation; Methylprednisolone; Necrosis; Swine; Transplantation, Heterotopic; Transplantation, Homologous | 1997 |
How to diagnose chronic rejection. A study in porcine intestinal allografts.
Topics: Abscess; alpha-Glucosidases; Animals; Atrophy; Cyclosporine; Epithelial Cells; Female; Graft Rejection; Ileum; Immunosuppressive Agents; Inflammation; Intestinal Mucosa; Methylprednisolone; Microvilli; Sucrase; Swine; Transplantation, Homologous; Vacuoles; Zidovudine | 1997 |
Role of chronic inflammation in the promotion of prostatic hyperplasia in rats.
Topics: Acyclic Monoterpenes; Animals; Cell Division; Cyclosporine; Freund's Adjuvant; Immunosuppressive Agents; Inflammation; Male; Monoterpenes; Prostate; Prostatic Hyperplasia; Prostatitis; Rats; Rats, Wistar; Terpenes; Vasodilator Agents | 1998 |
Cyclosporin A treatment and airways inflammation in corticosteroid-dependent asthma.
Topics: Adrenal Cortex Hormones; Asthma; Biopsy; Bronchi; Bronchoalveolar Lavage Fluid; Cell Count; Cyclosporine; Humans; Immunosuppressive Agents; Inflammation; Male; Middle Aged | 1998 |
Effect of inhaled cyclosporin on the rat airway: histologic and bronchoalveolar lavage assessment.
Topics: Administration, Inhalation; Animals; Asthma; Bronchi; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cyclosporine; Disease Models, Animal; Immunosuppressive Agents; Inflammation; Leukocyte Count; Macrophages; Ovalbumin; Rats; Rats, Sprague-Dawley; Reference Values | 1998 |
Effect of inhaled ingredients of a commercial cyclosporin A ampoule on airway inflammation.
Topics: Administration, Inhalation; Animals; Asthma; Bronchi; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cyclosporine; Disease Models, Animal; Eosinophils; Immunosuppressive Agents; Inflammation; Leukocyte Count; Ovalbumin; Rats | 1998 |
[Repetitive instillations of cyclosporin A eyedrop induce pupillary constriction and anterior chamber inflammation-like reactions in rabbits].
Topics: Animals; Anterior Chamber; Cyclosporine; Female; Immunosuppressive Agents; In Vitro Techniques; Inflammation; Miosis; Ophthalmic Solutions; Rabbits | 1998 |
Contribution of the inflammatory response to cardiac allograft rejection: histopathologic analysis of serial endomyocardial biopsies.
Topics: Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biopsy; Cyclosporine; Graft Rejection; Heart Transplantation; Humans; Immunophenotyping; Immunosuppression Therapy; Inflammation; Macrophages; Receptors, Interleukin-2; Time Factors | 1998 |
Inflammatory basis of asthma.
Topics: Animals; Asthma; CD4-Positive T-Lymphocytes; Cell Degranulation; Cyclosporine; Disease Models, Animal; Eosinophils; Humans; Immunosuppressive Agents; Inflammation; Mast Cells | 1993 |
Cyclosporin A reduces the inflammatory response to a multi-mutant herpes simplex virus type-1 leading to improved transgene expression in sympathetic preganglionic neurons in hamsters.
Topics: Adrenal Glands; Animals; beta-Galactosidase; Cricetinae; Cyclosporine; Defective Viruses; Genetic Vectors; Herpesvirus 1, Human; Histocytochemistry; Immunosuppressive Agents; Inflammation; Male; Mesocricetus; Methylprednisolone; Spinal Cord; Sympathetic Nervous System; Time Factors; Transgenes; Virus Replication | 1999 |
Comparative effects of betamethasone, cyclosporin and nedocromil sodium in acute pulmonary inflammation and metalloproteinase activities in bronchoalveolar lavage fluid from mice exposed to lipopolysaccharide.
Topics: Animals; Anti-Inflammatory Agents; Basement Membrane; Betamethasone; Bronchoalveolar Lavage; Cyclosporine; Cytokines; Glucocorticoids; Immunosuppressive Agents; Inflammation; Lipopolysaccharides; Lung Diseases; Metalloendopeptidases; Mice; Mice, Inbred BALB C; Nedocromil | 1999 |
Repeated measurement of intestinal permeability as an assessment of colitis severity in HLA-B27 transgenic rats.
Topics: Animals; Biomarkers; Colitis; Colon; Contrast Media; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Feces; HLA-B27 Antigen; Humans; Inflammation; Intestinal Mucosa; Leukocytes, Mononuclear; Male; Organ Size; Permeability; Rats; Rats, Inbred F344; Rats, Mutant Strains; Sulfasalazine; Time Factors; Triiodobenzoic Acids | 1999 |
Functional, histological, and inflammatory changes in chronically rejecting small bowel transplants.
Topics: Animals; Body Weight; Chronic Disease; Cyclosporine; Graft Rejection; Immunohistochemistry; Immunosuppressive Agents; Inflammation; Intestine, Small; Male; Rats; Rats, Inbred Strains; Serum Albumin; Transplantation, Homologous; Transplantation, Isogeneic | 2000 |
Control of IL-5 production by human helper T cells as a treatment for eosinophilic inflammation: comparison of in vitro and in vivo effects between selective and nonselective cytokine synthesis inhibitors.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Asthma; Clone Cells; Cyclosporine; Dexamethasone; Disease Models, Animal; Dose-Response Relationship, Drug; Eosinophilia; Humans; Immunosuppressive Agents; Inflammation; Interleukin-2; Interleukin-4; Interleukin-5; Macrolides; Mice; Mice, Inbred BALB C; T-Lymphocytes; T-Lymphocytes, Helper-Inducer; Tacrolimus | 2000 |
Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation.
Topics: Administration, Topical; Animals; Arginine; Biological Transport; Biotinylation; Cyclosporine; Cyclosporins; Humans; Inflammation; Interleukin-2; Ionomycin; Jurkat Cells; Mice; Mice, Inbred BALB C; Molecular Structure; Prodrugs; Skin; Skin Absorption; Tetradecanoylphorbol Acetate | 2000 |
Successful conversion from cyclosporine to tacrolimus for immunosuppression.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Biopsy, Needle; Chemical and Drug Induced Liver Injury; Cyclosporine; Diabetes Mellitus, Type 1; Female; Humans; Immunosuppressive Agents; Inflammation; Insulin; Liver Function Tests; Liver Transplantation; Male; Neutrophils; Tacrolimus | 2000 |
Function of inflammatory cells and neoral cyclosporin-A in heart transplant-associated coronary vasculopathy.
Topics: Actins; Animals; Coronary Disease; Coronary Vessels; Cyclosporine; Emulsions; Heart Transplantation; Immunohistochemistry; Immunosuppressive Agents; Inflammation; Male; Neovascularization, Pathologic; Rats; Rats, Inbred F344; Rats, Inbred Lew | 2001 |
Role of mast cells in antigen-induced airway inflammation and bronchial hyperresponsiveness in rats.
Topics: Acetylcholine; Animals; Anti-Inflammatory Agents; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cromolyn Sodium; Cyclosporine; Female; Immunosuppressive Agents; Inflammation; Leukocyte Count; Mast Cells; Ovalbumin; Passive Cutaneous Anaphylaxis; Prednisolone; Rats; Rats, Inbred BN; Rats, Wistar; Tacrolimus; Terfenadine | 2001 |
Anaplastic large-cell lymphoma which showed severe inflammatory status and myelodysplasia with increased VEGF and IL-6 serum levels after long-term immunosuppressive therapy.
Topics: Abdominal Pain; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Bleomycin; Bone Marrow; CD4-CD8 Ratio; Cell Lineage; Combined Modality Therapy; Cyclosporine; Dacarbazine; DNA, Neoplasm; DNA, Viral; Doxorubicin; Endothelial Growth Factors; Fever; Fibroblast Growth Factor 2; Gene Rearrangement, B-Lymphocyte; Humans; Immunocompromised Host; Immunosuppressive Agents; Inflammation; Interleukin-6; Lymph Nodes; Lymphokines; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Myelodysplastic Syndromes; Pancytopenia; Prednisolone; Remission Induction; Splenectomy; Syndrome; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vinblastine | 2001 |
MC1288, a vitamin D analog, prevents acute graft-versus-host disease in rat bone marrow transplantation.
Topics: Acute Disease; Animals; Biomarkers; Bone Marrow Transplantation; Calcitriol; Cyclosporine; Graft vs Host Disease; Immunosuppressive Agents; Inflammation; Liver; Models, Animal; Rats; Rats, Inbred Lew; Skin; Spleen | 2001 |
Critical role for T cells in Sephadex-induced airway inflammation: pharmacological and immunological characterization and molecular biomarker identification.
Topics: Acetylcholine; Animals; Antibodies, Monoclonal; Biomarkers; Bradykinin; Bronchial Hyperreactivity; Budesonide; Cell Movement; Cells, Cultured; Cyclosporine; Cytokines; Dextrans; Gene Expression Regulation; Inflammation; Interleukin-2; Intubation, Intratracheal; Lung; Lymphocyte Depletion; Male; Mast Cells; Pulmonary Eosinophilia; Rats; Rats, Sprague-Dawley; T-Lymphocyte Subsets; Time Factors | 2002 |
Psoriasis: current concepts and new approaches to therapy.
Topics: Cyclosporine; Dietary Fats; Eicosanoids; Eicosapentaenoic Acid; Fatty Acids, Essential; Humans; Inflammation; Lymphokines; Malondialdehyde; Models, Biological; Psoriasis; Superoxides | 1992 |
Cyclosporine in the treatment of nonmicrobial inflammatory ophthalmic disease.
Topics: Adolescent; Adult; Aged; Choroiditis; Corneal Transplantation; Cyclosporine; Eye Diseases; Female; Follow-Up Studies; Graft Rejection; Humans; Inflammation; Male; Middle Aged; Ophthalmia, Sympathetic; Prognosis; Uveitis, Intermediate | 1992 |
Histologic classification of pancreatic allograft rejection in the rat.
Topics: Animals; Arteries; Cyclosporine; Diabetes Mellitus, Experimental; Endothelium, Vascular; Graft Rejection; Graft vs Host Disease; Immunosuppression Therapy; Inflammation; Pancreas Transplantation; Rats; Rats, Inbred BN; Rats, Inbred Lew; Time Factors | 1992 |
Apoptosis in the nervous system in experimental allergic encephalomyelitis.
Topics: Animals; Cyclosporine; Demyelinating Diseases; Encephalomyelitis, Autoimmune, Experimental; Ganglia, Spinal; Immunization, Passive; Inflammation; Meninges; Microscopy, Electron; Myelin Basic Protein; Nerve Degeneration; Rats; Rats, Inbred Strains; Spinal Cord; Spleen | 1991 |
[Role of macrophages and T-lymphocytes: resistance of guinea pigs to amebic liver infection].
Topics: Animals; Cyclosporine; Entamoeba histolytica; Guinea Pigs; Immunity, Cellular; Immunity, Innate; Inflammation; Ischemia; Liver; Liver Abscess, Amebic; Macrophages; Necrosis; T-Lymphocytes | 1990 |